{
  "meta": {
    "title": "00074_Late_Night_Pyq_Pyt_Marathon_Pharma-1",
    "url": "https://brainandscalpel.vercel.app/00074-late-night-pyq-pyt-marathon-pharma-1-59b19f21.html",
    "scrapedAt": "2025-11-29T17:25:18.935Z"
  },
  "questions": [
    {
      "id": 6518,
      "choices": [
        {
          "id": 26041,
          "text": "<p><span style=\"font-size:12.0pt;\">Aliskiren</span></p>"
        },
        {
          "id": 26042,
          "text": "<p><span style=\"font-size:12.0pt;\">Chlorthalidone</span></p>"
        },
        {
          "id": 26043,
          "text": "<p><span style=\"font-size:12.0pt;\">Amlodipine</span></p>"
        },
        {
          "id": 26044,
          "text": "<p><span style=\"font-size:12.0pt;\">Prazosin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with renal insufficiency had very low urine output, pedal edema, headache, and a blood pressure of 160/90. Which antihypertensive medication can be used? (NEET PG 2021)</span></p>",
      "unique_key": "Q8607196",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993840,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Amlodipine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a patient with renal insufficiency and low urine output, the preferred antihypertensive medication would be one that is safe in renal failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Amlodipine is a good choice because it is a calcium channel blocker that does not affect renal function. Although it can cause pedal edema in some patients but the pedal edema which is given in the question seems to be due to renal insufficiency itself. The adverse effect of pedal edema does not make it contra-indicated for hypertension.&nbsp;&nbsp;It also has a long duration of action and is well-tolerated in patients with renal insufficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aliskiren: </strong>Aliskiren is a direct renin inhibitor that can lead to severe hyperkalemia, particularly in patients with renal insufficiency. Hyperkalemia can exacerbate renal dysfunction and pose serious health risks, making aliskiren an unsuitable choice for this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Chlorthalidone: </strong>Chlorthalidone is a thiazide-like diuretic. Thiazide diuretics are typically ineffective in patients with significantly impaired renal function (e.g., low GFR) and can cause electrolyte imbalances, including hypokalemia and hyponatremia. Therefore, chlorthalidone is not recommended for patients with renal insufficiency and low urine output.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Prazosin: </strong>Prazosin is an alpha-blocker used to lower blood pressure. However, it is not typically a first-line drug for hypertension due to its side effects, such as postural hypotension. Additionally, prazosin can cause fluid retention, which may worsen renal function in patients with renal insufficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Amlodipine is the preferred antihypertensive medication for patients with renal insufficiency, as it effectively lowers blood pressure without negatively impacting renal function.</span></p>",
      "correct_choice_id": 26043,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33867,
      "choices": [
        {
          "id": 135306,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase dose of haloperidol </span></span></p>"
        },
        {
          "id": 135307,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Change haloperidol to clozapine</span></span></p>"
        },
        {
          "id": 135308,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Give fluphenzine instead of haloperidol</span></span></p>"
        },
        {
          "id": 135309,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Give benztropine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient of Schizophrenia was started on antipsychotic drug haloperidol. Few hours later, he presented with torticollis and muscular dystonia. What is the next best step for the management of this patient?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Fmge Jan 2024)</span></span></p>",
      "unique_key": "Q8642180",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055229,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. D. Give benztropine</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">When a patient on haloperidol develops extrapyramidal symptoms (EPS) like torticollis and muscular dystonia, the next best step is typically to administer an anticholinergic medication like benzhexol or benztropine to alleviate these side effects. Increasing the dose of haloperidol would likely worsen the EPS, while changing to clozapine is an option for patients with severe EPS or a history of non-response to other treatments. Fluphenazine is unlikely to be significantly different from haloperidol in causing EPS.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options: </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong> <strong>Increase dose of haloperidol:</strong> Increasing the dose of haloperidol is not the appropriate response when a patient develops extrapyramidal symptoms (EPS) such as torticollis and muscular dystonia. It can exacerbate these side effects.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> <strong>Change haloperidol to clozapine:</strong> Clozapine is an atypical antipsychotic that is less likely to cause EPS compared to typical antipsychotics like haloperidol. Switching to clozapine can be a reasonable option to manage EPS.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong> <strong>Give fluphenzine instead of haloperidol:</strong> Fluphenazine is another typical antipsychotic and is not expected to be significantly different from haloperidol in terms of causing EPS. Switching to fluphenazine may not effectively address the EPS.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective: </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benztropine is an anticholinergic medication commonly used to manage extrapyramidal symptoms (EPS) caused by antipsychotic medications. It can be an appropriate choice to alleviate the torticollis and muscular dystonia.</span></span></p>",
      "correct_choice_id": 135309,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31845,
      "choices": [
        {
          "id": 127250,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1% Atropine </span></span></p>"
        },
        {
          "id": 127251,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">0.5% Loteprednol </span></span></p>"
        },
        {
          "id": 127252,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1% Tropicamide </span></span></p>"
        },
        {
          "id": 127253,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">0.5% Timolol</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 5-year-old child was brought to the hospital by their parents with symptoms of squint and diminished vision. For conducting refraction testing on this child, which of the following drugs would be most suitable? (Fmge July 2023)</span></span></p>",
      "unique_key": "Q9295993",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055164,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) 1% Atropine</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1% Atropine is the most suitable drug for refraction testing in a child with squint and diminished vision. Atropine is used as a cycloplegic agent to paralyze the ciliary muscle of the eye, enabling accurate measurement of refractive error, especially in children where accommodative spasm can interfere with the results.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. 1% Tropicamide:</strong> Although tropicamide is also a mydriatic and cycloplegic agent, its cycloplegic action is less pronounced than atropine. As a child is likely to have higher tone of ciliary muscle, it is not reliable drug for cycloplegic action in children.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. 0.5% Loteprednol:</strong> This is a corticosteroid used for inflammation, not appropriate for refraction testing.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. 0.5% Timolol:</strong> A beta-blocker used for glaucoma treatment, not suitable for pupil dilation or refraction testing.</span></span>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective: </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1% Atropine is the most effective cycloplegic agent for refraction testing in children, providing reliable and accurate measurement of refractive error by paralyzing the ciliary muscle and preventing accommodation.</span></span></p>",
      "correct_choice_id": 127250,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 52361,
      "choices": [
        {
          "id": 208937,
          "text": "<p><span style=\"font-size:12.0pt;\">Resting zone</span></p>"
        },
        {
          "id": 208938,
          "text": "<p><span style=\"font-size:12.0pt;\">Proliferative zone</span></p>"
        },
        {
          "id": 208939,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertrophic zone</span></p>"
        },
        {
          "id": 208940,
          "text": "<p><span style=\"font-size:12.0pt;\">Zone of provisional calcification</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Salter Harris Type 1 injury passes through which zone?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q7207983",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993445,
      "difficulty_level": "intermediate",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Hypertrophic zone&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>SALTER HARRIS CLASSIFICATION&nbsp;</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">The <strong>arrangement of cells of the physis</strong> is in layers or zones.&nbsp;</span></li><li><span style=\"font-size:16px;\">These layers&nbsp;include the <strong>reserve, proliferative and hypertrophic</strong> zones.&nbsp;</span></li><li><span style=\"font-size:16px;\">The <strong>reserve zone</strong> serves as the <strong>storage area</strong> for lipids, proteoglycans, and glycogen for growth and&nbsp;<strong>matrix production</strong> later.&nbsp;</span></li><li><span style=\"font-size:16px;\">The <strong>proliferative zone</strong> has the <strong>highest rate of extracellular matrix production</strong> and accounts for the <strong>most abundant longitudinal growth</strong>.&nbsp;</span></li><li><span style=\"font-size:16px;\">The <strong>hypertrophic zone has three phases</strong>:&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\"><strong>Maturation</strong> allows for preparation for calcification</span></li><li><span style=\"font-size:16px;\"><strong>Degenerative</strong> further prepare the matrix</span></li><li><span style=\"font-size:16px;\"><strong>Provisional calcification zone</strong> is where chondrocyte death occurs, allowing for <strong>calcium release</strong>.&nbsp;</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Physeal fractures</strong>&nbsp;most commonly occur in the <strong>zone of provisional calcification</strong>, as it is the <strong>weakest</strong> in response to shearing stress.&nbsp;</span></li><li><span style=\"font-size:16px;\">The physis is weaker than ligaments or periosteum in children, causing injury to the growth plate before other structures.&nbsp;</span></li><li><span style=\"font-size:16px;\"><strong>Zones of physis:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-13%20155714.jpeg\" width=\"845\" height=\"771\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/25/screenshot-2024-07-25-131600.jpg\" alt=\"\" width=\"700\" height=\"788\"></strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Salter and Harris described two major types of epiphyseal plates</strong>: the <strong>pressure</strong> epiphysis and the <strong>traction</strong> epiphysis.&nbsp;</span></li><li><span style=\"font-size:16px;\"><strong>Pressure epiphyses provide longitudinal growth</strong>, at the end of long bones, are <strong>intra-articular</strong>, and <strong>bear weight</strong>.&nbsp;</span></li><li><span style=\"font-size:16px;\"><strong>Traction epiphyses provide appositional growth</strong>, at the origin or insertion of muscles, are <strong>extra-articular</strong>, and <strong>do not bear weight</strong>.&nbsp;</span></li><li><span style=\"font-size:16px;\">Their classification focuses on injuries at pressure epiphyses.&nbsp;</span></li><li><span style=\"font-size:16px;\">They recognized that physeal fractures consistently occur through the same histologic plane called the <strong>zone of provisional calcification</strong>.&nbsp;</span></li><li><span style=\"font-size:16px;\">This zone, <strong>located in the zone of hypertrophy</strong>, represents a <strong>transitional point between calcified and non-calcified extracellular matrix proteins</strong>, making it <strong>weaker</strong> than its surrounding osseous-ligamentous structures, and therefore <strong>more susceptible to injury.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/25/screenshot-2024-07-25-131827.jpg\" alt=\"\" width=\"700\" height=\"243\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">In <strong>type I injury</strong>, there is <strong>slip of epiphysis</strong> with <strong>damage to the hypertrophic zone</strong> of the physis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Resting zone:</strong> It is affected in storage disorders like Gaucher’s disease.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Proliferative zone:</strong> It is affected in growth hormone defects like Larsen’s syndrome.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Zone of provisional calcification:</strong> It is affected in mineralization defects like rickets.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Hypertrophic zone of the physis has a high bone turnover.&nbsp;</span></li><li><span style=\"font-size:16px;\">It is the area where all Salter-Harris injuries occur.&nbsp;</span></li><li><span style=\"font-size:16px;\">Thus, the Type I injuries occurs in the hypertrophic zone of the physis.&nbsp;</span></li></ul>",
      "correct_choice_id": 208939,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24709,
      "choices": [
        {
          "id": 98797,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lapatinib</span></span></span></p>"
        },
        {
          "id": 98798,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sorafenib</span></span></span></p>"
        },
        {
          "id": 98799,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vismodegib</span></span></span></p>"
        },
        {
          "id": 98800,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erlotinib</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old female is diagnosed with breast cancer. Her tumor is found to be HER2-positive but estrogen receptor (ER) and progesterone receptor (PR) negative. The tumor was resistant to trastuzumab.<strong> </strong>Which of the following drugs is most likely to be effective in the treatment of this patient&#39;s breast cancer?</span></span>(INICET MAY 2023)</p>",
      "unique_key": "Q3073463",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993320,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Lapatinib</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lapatinib is a tyrosine kinase inhibitor that can be used for the treatment of HER2-positive but trastuzumab-resistant breast cancer. Trastuzumab is a monoclonal antibody that is commonly used for the treatment of HER2-positive breast cancer, but some patients may develop resistance to this drug over time. Lapatinib works by targeting the HER2 receptor, which is overexpressed in HER2-positive breast cancer, and can be effective in treating breast cancer that has become resistant to trastuzumab. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong><span style=\"font-size:12.0pt\"> Sorafenib is a kinase inhibitor that is primarily used for the treatment of advanced liver cancer and kidney cancer. It works by blocking the activity of several proteins that promote the growth and spread of cancer cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong><span style=\"font-size:12.0pt\"> Vismodegib is a hedgehog pathway inhibitor that is used for the treatment of basal cell carcinoma, a type of skin cancer. It works by blocking the hedgehog signalling pathway, which is involved in the development and growth of cancer cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong><span style=\"font-size:12.0pt\"> Erlotinib is a tyrosine kinase inhibitor that is used for the treatment of non-small cell lung cancer, pancreatic cancer, and other types of cancer. It works by blocking the activity of the epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lapatinib is an effective treatment for HER2-positive breast cancer, especially in cases where the cancer has become resistant to trastuzumab. It works by targeting the HER2 receptor and can help manage this specific type of breast cancer.</span></span></span></p>",
      "correct_choice_id": 98797,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6422,
      "choices": [
        {
          "id": 25657,
          "text": "<p><span style=\"font-size:12.0pt;\">Lignocaine</span></p>"
        },
        {
          "id": 25658,
          "text": "<p><span style=\"font-size:12.0pt;\">Quinidine</span></p>"
        },
        {
          "id": 25659,
          "text": "<p><span style=\"font-size:12.0pt;\">Magnesium sulfate</span></p>"
        },
        {
          "id": 25660,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs is associated with QT prolongation?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q7781448",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055152,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Quinidine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Quinidine is a Class Ia anti arrhythmic drug that acts by blocking Na+ channels as well as K+&nbsp;channels. It can lead to prolonged QT interval and Torsades de pointes.&nbsp;Flecainide, Encainide and Propafenone are other drugs that belong to Class Ic antiarrhythmics and can also precipitate Torsades de pointes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lignocaine:&nbsp;</strong>Lignocaine (lidocaine) is a Class Ib antiarrhythmic drug that primarily blocks sodium channels. It does not significantly affect the QT interval and is not associated with QT prolongation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Magnesium sulfate:&nbsp;</strong>Magnesium sulfate is used to treat Torsades de Pointes and other arrhythmias but does not cause QT prolongation. In fact, it is often administered to help stabilize the cardiac electrical activity in cases of prolonged QT interval.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. All of the above:&nbsp;</strong>This option is incorrect because neither lignocaine nor magnesium sulfate is associated with QT prolongation. Only quinidine is known to cause QT prolongation among the listed drugs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Class Ia Antiarrhythmics</strong>: These drugs, including quinidine, procainamide, and disopyramide, are known to prolong the QT interval by blocking both Na+ and K+ channels.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Class Ic Antiarrhythmics</strong>: Drugs like flecainide, encainide, and propafenone can also precipitate Torsades de Pointes, although their primary action is on Na+ channels.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Quinidine, a Class Ia antiarrhythmic drug, is associated with QT prolongation and can lead to Torsades de Pointes due to its action on both sodium and potassium channels.</span></p>",
      "correct_choice_id": 25658,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20909,
      "choices": [
        {
          "id": 83600,
          "text": "<p><span style=\"font-size:12.0pt;\">Carboprost</span></p>"
        },
        {
          "id": 83601,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxytocin</span></p>"
        },
        {
          "id": 83602,
          "text": "<p><span style=\"font-size:12.0pt;\">Dinoprostone</span></p>"
        },
        {
          "id": 83603,
          "text": "<p><span style=\"font-size:12.0pt;\">Methyl ergometrine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A pregnant woman with a history of bronchial asthma in third stage of labor. Which of the following drugs should be avoided in the management of postpartum hemorrhage in this patient? (NEET PG 2023)</span></p>",
      "unique_key": "Q7116298",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993496,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A) Carboprost</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The drug that should be avoided in this patient with a history of bronchial asthma is carboprost since it can cause bronchoconstriction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><u>Carboprost (PGF2α analogue)</u></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Action - It increases uterine tone by contracting upper segment of uterus</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Use - To control postpartum hemorrhage (DOC – Oxytocin).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A/E - Vomiting, diarrhea, and bronchoconstriction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Contraindications -</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-164227.png\" alt=\"\" width=\"1000\" height=\"220\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Oxytocin</strong></span><span style=\"font-size:12pt;\">: Oxytocin is the first-line drug to prevent and treat PPH and also used in augmentation of labour according to WHO guidelines. Administered by intravenous route and may lead to hypotension and reflex tachycardia.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. Dinoprostone</strong>: Dinoprostone is a PGE2 analogue used for cervical ripening, induction of labor, and in atony treatment. It should be avoided in patients with a history of asthma, glaucoma, or myocardial infarction. One major adverse effect is uterine hyperstimulation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Methyl ergometrine:</strong> Ergot derivatives are used in the control of postpartum uterine bleeding. It is given intramuscularly and is effective within 1-5 minutes. It is given at the time of delivery of the placenta or immediately after if bleeding is significant. Side effects are gastrointestinal disturbances like diarrhea, nausea, and vomiting.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Carboprost should be avoided in the management of postpartum hemorrhage in patients with a history of bronchial asthma due to its potential to cause bronchoconstriction.</span></p>",
      "correct_choice_id": 83600,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3460,
      "choices": [
        {
          "id": 13819,
          "text": "<p><span style=\"font-size:12.0pt;\">Echinococcus granulosus</span></p>"
        },
        {
          "id": 13820,
          "text": "<p><span style=\"font-size:12.0pt;\">Schistosoma japonicum</span></p>"
        },
        {
          "id": 13821,
          "text": "<p><span style=\"font-size:12.0pt;\">Trypanosoma cruzi</span></p>"
        },
        {
          "id": 13822,
          "text": "<p><span style=\"font-size:12.0pt;\">Schistosoma mansoni</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the causative organism for the condition shown in the image below?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-256.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p>",
      "unique_key": "Q4996812",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993508,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Echinococcus granulosus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image shows a hydatid cyst in the liver. Large, unilocular/multilocular, well-defined, hypodense cysts. Contains multiple internal “daughter” cysts of lower density than “mother” cyst (exocyst). Curvilinear ring-like calcification of pericyst (wall).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Causative organism – Echinococcus granulosus</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Definitive hosts – Dogs, Intermediate host – Sheep, Accidental intermediate host – Human</strong> (end stage host)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the liver, the pressure effect of the cyst can produce symptoms of <u>obstructive jaundice</u> and abdominal pain. <u>With biliary rupture, the classic triad of biliary colic, jaundice, and urticaria</u> is observed. Passage of hydatid membranes in the emesis (hydatid emesia) and passage of membranes in the stools (hydatid enterica) may occur rarely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-26.jpg\" alt=\"\" width=\"700\" height=\"514\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Schistosoma japonicum</strong>: This parasitic worm causes schistosomiasis, primarily affecting the intestines and liver, but it does not form hydatid cysts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Trypanosoma cruzi</strong>: This protozoan parasite causes Chagas disease, which primarily affects the heart and digestive system, not forming cysts in the liver.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Schistosoma mansoni</strong>: This parasitic worm also causes schistosomiasis, affecting the intestines and liver, but it does not form hydatid cysts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The condition shown in the image, characterized by a hydatid cyst in the liver, is caused by Echinococcus granulosus. The cysts contain internal daughter cysts and can lead to symptoms related to the pressure effect on the liver and biliary system.</span></p>",
      "correct_choice_id": 13819,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13945,
      "choices": [
        {
          "id": 55741,
          "text": "<p><span style=\"font-size:12.0pt;\">Strap his thorax, abdomen and lower limbs on a stretcher</span></p>"
        },
        {
          "id": 55742,
          "text": "<p><span style=\"font-size:12.0pt;\">Apply a cervical collar</span></p>"
        },
        {
          "id": 55743,
          "text": "<p><span style=\"font-size:12.0pt;\">Put patient on lateral position and shift him immediately</span></p>"
        },
        {
          "id": 55744,
          "text": "<p><span style=\"font-size:12.0pt;\">Roll the patient and put on a hard board</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are done to transport a polytrauma patient who is conscious except? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q9309920",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993498,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Put patient on lateral position and shift him immediately</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This option is not a standard practice when transporting conscious polytrauma patients. Shifting a conscious patient to a lateral position and immediately moving them can risk further injury and discomfort.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Strap his thorax, abdomen, and lower limbs on a stretcher:&nbsp;</strong>This is a common and necessary practice when transporting a conscious polytrauma patient. It helps secure the patient to the stretcher to prevent movement and further injury during transport.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Apply a cervical collar:&nbsp;</strong>This is done to immobilize the cervical spine, till a cervical injury is ruled out.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Roll the patient and put on a hardboard:&nbsp;</strong>Rolling a conscious polytrauma patient and placing them on a hardboard (spinal board) can be a part of the standard protocol for immobilizing the spine and minimizing movement during transport. This is done to prevent potential spinal cord injuries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients with polytrauma are shifted in supine or prone position (not in lateral position) by laying them over a firm surface, in order to restrict the spinal movement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As per ATLS guidelines, in patients with trauma, airway management is first done along with cervical spine stabilization. All trauma patients unless proven otherwise are considered to have an injured vertebral column.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is placed supine on a firm surface without rotating or bending the spinal column and a rigid cervical collar (Philadelphia collar) is applied.</span></p>",
      "correct_choice_id": 55743,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5423,
      "choices": [
        {
          "id": 21664,
          "text": "<p><span style=\"font-size:12.0pt;\">The efficacy of the drug b and c are equal</span></p>"
        },
        {
          "id": 21665,
          "text": "<p><span style=\"font-size:12.0pt;\">Drug A is the most potent drug</span></p>"
        },
        {
          "id": 21666,
          "text": "<p><span style=\"font-size:12.0pt;\">Drug C is less potent and equally efficacious to drug B</span></p>"
        },
        {
          "id": 21667,
          "text": "<p><span style=\"font-size:12.0pt;\">Drug D is more potent than drugs A, B &amp; C, but less efficacious than drugs A &amp; B, and equally efficacious as drug C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the true statement about the given dose-response curve? (Fmge Jan 2023)</span></p><p>&nbsp;</p><p><i><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/1_yGwcqtN.jpg\" alt=\"\" width=\"300\" height=\"299\"></i></p>",
      "unique_key": "Q1408038",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055154,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. D. Drug D is more potent than drugs A, B &amp; C, but less efficacious than drugs A &amp; B and equally efficacious as drug C</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The above given image is that of a Log Dose-Response curve, where on the X axis we plot the Log concentration of the drug and on the Y axis we plot the Response. From this type of curve , we can know about the following 3 parameters about a drug:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Potency</strong> – Potency means the power of a drug. The drug which produces the response at a lower dose is more potent than another drug which produces the same response at a higher dose.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Efficacy</strong> – It is the maximum response produced by a drug. The maximum height of the curve corresponds to the efficacy, or in other words, the more the height of the curve, the more efficacious that drug becomes.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Safety</strong> – The slope of the curve is related to the safety of the drug. The drug with a steeper slope is less safe than a drug with a flatter slope.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In the given graph:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Potency</strong>: D &gt; A &gt; B &gt; C</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Efficacy</strong>: A = B &gt; C = D</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. </strong>The efficacy of both drugs A and B are equal and the efficacy of drugs D and C are equal.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. </strong>Drug D is the most potent drug</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. </strong>Drug C is less potent but equally efficacious to drug D</span></p><p style=\"margin-left:72px;text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In the given Log Dose-Response curve, Drug D is the most potent drug but is less efficacious than drugs A and B, and equally efficacious as drug C. Potency is determined by the position of the curve along the X-axis, while efficacy is determined by the maximum height of the curve.</span></p>",
      "correct_choice_id": 21667,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24711,
      "choices": [
        {
          "id": 98805,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The ratio of the median lethal dose to the median effective dose in an individual. </span></span></span></p>"
        },
        {
          "id": 98806,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The range of doses at which a drug is effective without causing significant adverse effects. </span></span></span></p>"
        },
        {
          "id": 98807,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The ratio of the median lethal dose to the median effective dose in a population. </span></span></span></p>"
        },
        {
          "id": 98808,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The dosage at which a drug is both safe and effective in the majority of patients.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical </span><span style=\"font-size:12.0pt\">Therapeutic Index of a drug is best described as:&nbsp;</span></span></span>(INICET MAY 2023)</p>",
      "unique_key": "Q3673197",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055155,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C. The ratio of the median lethal dose to the median effective dose in a population.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Clinical Therapeutic Index of a drug is best described as the ratio of the median lethal dose (LD50) to the median effective dose (ED50). Both LD50 and ED50 are calculated by checking different doses in a population. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It represents the margin of safety of a drug. A higher Clinical Therapeutic Index indicates that a drug has a greater margin of safety, and can be given at higher doses without causing significant adverse effects. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Clinical Therapeutic Index is an important consideration in the development and use of new medications, and helps healthcare providers determine the appropriate dose for individual patients.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:24px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. The ratio of the median lethal dose to the median effective dose in an individual</span></strong><span style=\"font-size:12.0pt\">: This description is incorrect because the therapeutic index is determined based on population data, not individual data.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. The range of doses at which a drug is effective without causing significant adverse effects</span></strong><span style=\"font-size:12.0pt\">: This describes the therapeutic window or therapeutic range, not the therapeutic index.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. The dosage at which a drug is both safe and effective in the majority of patients</span></strong><span style=\"font-size:12.0pt\">: This is a general description of an effective and safe dosage regimen but does not specifically describe the therapeutic index.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Clinical Therapeutic Index of a drug is the ratio of the median lethal dose (LD50) to the median effective dose (ED50) in a population, representing the drug&#39;s margin of safety. A higher Therapeutic Index indicates a greater margin of safety.</span></span></span></p>",
      "correct_choice_id": 98807,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 64642,
      "choices": [
        {
          "id": 257765,
          "text": "<p><span style=\"font-size:12.0pt;\">Amoxicillin-clavulanate</span></p>"
        },
        {
          "id": 257766,
          "text": "<p><span style=\"font-size:12.0pt;\">Valproate</span></p>"
        },
        {
          "id": 257767,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin</span></p>"
        },
        {
          "id": 257768,
          "text": "<p><span style=\"font-size:12.0pt;\">Paracetamol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Most commonly implicated drug for idiosyncratic drug-induced liver injury is? (Twisted PYQ)</span></p>",
      "unique_key": "Q8194705",
      "question_audio": null,
      "question_video": null,
      "map_id": 15173100,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Amoxicillin-clavulanate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Idiosyncratic drug-induced liver injury (DILI) occurs unpredictably and is unrelated to drug dose or duration. Amoxicillin-clavulanate is one of the most common causes of idiosyncratic DILI globally, often manifesting as a cholestatic or mixed pattern of liver injury. It is distinct from dose-dependent liver injury, such as that caused by paracetamol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Valproate:</strong> Valproate-induced liver injury is typically idiosyncratic but less frequent than amoxicillin-clavulanate. Risk factors include young age and polytherapy with other antiepileptic drugs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Warfarin:</strong> Warfarin rarely causes hepatotoxicity and is not a common cause of DILI. Its primary concerns relate to bleeding due to its anticoagulant effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Paracetamol:</strong> Paracetamol is the leading cause of dose-dependent acute liver failure, not idiosyncratic DILI. Its toxicity is related to overdose or risk factors such as pre-existing liver disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Amoxicillin-clavulanate is a leading cause of idiosyncratic drug-induced liver injury, presenting unpredictably and often unrelated to dose or duration. This is distinct from dose-dependent hepatotoxicity like that caused by paracetamol.</span></p>",
      "correct_choice_id": 257765,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7034,
      "choices": [
        {
          "id": 28104,
          "text": "<p><span style=\"font-size:12pt;\">Protects the acid labile drug from gastric acidity</span></p>"
        },
        {
          "id": 28105,
          "text": "<p><span style=\"font-size:12pt;\">Protects the gastric mucosa from irritant effects of certain drugs</span></p>"
        },
        {
          "id": 28106,
          "text": "<p><span style=\"font-size:12pt;\">Prolongs the half-life of the drug</span></p>"
        },
        {
          "id": 28107,
          "text": "<p><span style=\"font-size:12pt;\">Delivers drugs distal to stomach</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Many drugs are given as enteric coated tablets. All of the following are the advantages of enteric coating of drugs EXCEPT? (AIIMS MAY 2020)</span><br>&nbsp;</p>",
      "unique_key": "Q6458337",
      "question_audio": null,
      "question_video": null,
      "map_id": 15251806,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Prolongs the half-life of the drug</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Enteric coatings on tablets protect acid-labile drugs from gastric acidity, protect the gastric mucosa from irritant effects, and deliver drugs distal to the stomach. However, they do not prolong the half-life of a drug, which is determined by the drug's metabolism and elimination from the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Enteric-coated drugs are designed with a special coating that resists dissolution in the acidic environment of the stomach. This coating dissolves instead in the more alkaline environment of the small intestine. The primary purposes of this enteric coating are:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Protect the acid-labile drug from gastric acidity:&nbsp;</strong>Some drugs are unstable in the acidic environment of the stomach and can be degraded before they have a chance to be absorbed. Enteric coating protects these drugs from the acidic gastric environment, ensuring they reach the intestine, where they can be absorbed effectively.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Protect the gastric mucosa from the irritant effects of certain drugs:&nbsp;</strong>Certain drugs can irritate the gastric mucosa, leading to discomfort or even ulcers. Enteric coating prevents these drugs from being released in the stomach, thereby reducing the risk of gastric irritation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Deliver drugs distal to the stomach:&nbsp;</strong>Enteric coating is also used to ensure that a drug is released in the intestine rather than the stomach, which can be important for drugs that are intended to act in the intestine or are better absorbed from the intestinal lining.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Enteric coating is primarily used to protect acid-labile drugs from gastric acidity, protect the gastric mucosa from irritant effects, and ensure drug delivery distal to the stomach. It does not prolong the half-life of the drug.</span></p>",
      "correct_choice_id": 28106,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44452,
      "choices": [
        {
          "id": 177455,
          "text": "<p>Ceftaroline</p>"
        },
        {
          "id": 177456,
          "text": "<p>Ceftolozane</p>"
        },
        {
          "id": 177457,
          "text": "<p>Cefpirome</p>"
        },
        {
          "id": 177458,
          "text": "<p>Ceftizoxime</p>"
        }
      ],
      "text": "<p>Which of the following is a fifth-generation cephalosporin active against MRSA? (NEET PG 2017)</p>",
      "unique_key": "Q4202986",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993315,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><strong>Correct Answer: A. Ceftaroline</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Ceftaroline is a fifth-generation cephalosporin specifically designed to be active against methicillin-resistant Staphylococcus aureus (MRSA). It differs from other cephalosporins by its ability to bind to the altered penicillin-binding proteins (PBPs) expressed in MRSA, particularly PBP2a, which confers methicillin resistance.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><ul><li><strong>Option B. Ceftolozane&nbsp;</strong>- This is not a fifth-generation cephalosporin with anti-MRSA activity. Ceftolozane is typically combined with tazobactam and has activity primarily against gram-negative bacteria including Pseudomonas.</li><li><strong>Option C. Cefpirome&nbsp;</strong>- Cefpirome is a fourth-generation cephalosporin without specific activity against MRSA.</li><li><strong>Option D. Ceftizoxime&nbsp;</strong>- This is a third-generation cephalosporin without activity against MRSA.</li></ul><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fifth-generation cephalosporins such as ceftaroline are distinguished by their ability to bind to altered PBPs in MRSA, making them effective against this resistant organism that is typically not susceptible to other β-lactam antibiotics.</span></p>",
      "correct_choice_id": 177455,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51444,
      "choices": [
        {
          "id": 205297,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Oral Nifedipine</span></p>"
        },
        {
          "id": 205298,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Oral Nicardipine capsules</span></p>"
        },
        {
          "id": 205299,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">IV Nitroglycerine</span></p>"
        },
        {
          "id": 205300,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Labetalol</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 52-year-old male presents with headache, confusion, visual disturbances, nausea, vomiting, and seizures. On examination, blood pressure is 220/110 mmHg. Which of the following treatments is most appropriate for managing his condition? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q6469890",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055231,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. D) IV Labetalol</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">This case presents a hypertensive emergency with signs of hypertensive encephalopathy, as indicated by the symptoms of headache, confusion, visual disturbances, nausea, vomiting, and seizures, along with severely elevated blood pressure (220/110 mmHg). In hypertensive emergencies, the goal is to rapidly reduce blood pressure using intravenous medications to prevent further organ damage.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">IV Labetalol is a preferred treatment in hypertensive emergencies, especially those involving encephalopathy. Labetalol is a combined alpha and beta-blocker that can reduce blood pressure quickly and effectively, making it ideal for this scenario.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. Oral Nifedipine:</strong> Oral nifedipine is not appropriate for hypertensive emergencies because it does not act rapidly enough, and oral medications are generally avoided in such acute settings.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. Oral Nicardipine capsules:</strong> Like oral nifedipine, oral nicardipine is not suitable for emergencies due to its slower onset of action. Nicardipine is more effective in its intravenous form for such cases.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. IV Nitroglycerine:</strong> Although IV nitroglycerine can be used in hypertensive emergencies, it is not the best choice for hypertensive encephalopathy. Nitroglycerine is more commonly used in cases involving acute coronary syndromes or pulmonary edema, but it is usually avoided in patients with CNS involvement.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>DOC for Hypertensive emergencies:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Encephalopathy </strong>- Nicardipine or IV Labetalol</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Intracranial Hemorrhage</strong> - Nicardipine or Labetalol</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Acute Coronary Syndrome</strong> – IV Nitroglycerin</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Pulmonary Edema</strong> - Intravenous Nitroglycerin / Sodium Nitroprusside</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Aortic Dissection</strong> – Nicardipine in combination with Esmolol or Labetalol</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>In Pregnancy </strong>- Labetalol</span></p></li></ul>",
      "correct_choice_id": 205300,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7050,
      "choices": [
        {
          "id": 28168,
          "text": "<p><span style=\"font-size:12.0pt;\">Adequate safety profile needs to be established</span></p>"
        },
        {
          "id": 28169,
          "text": "<p><span style=\"font-size:12.0pt;\">Cost to benefit has to be considered</span></p>"
        },
        {
          "id": 28170,
          "text": "<p><span style=\"font-size:12.0pt;\">Fixed dose combination of drugs is preferred over single drugs</span></p>"
        },
        {
          "id": 28171,
          "text": "<p><span style=\"font-size:12.0pt;\">Disease prevalence is considered</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is false about the selection of essential drugs? (INICET MAY 2021)</span></p>",
      "unique_key": "Q8002091",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993453,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Fixed dose combination of drugs is preferred over single drugs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The WHO has defined Essential Medicines (Drugs) as “those that satisfy the priority healthcare needs of the population. They are selected with due regard to public health relevance, evidence on efficacy and safety, and comparative cost effectiveness. Essential medicines are intended to be available within the context of functioning health systems at all times and in adequate amounts, in appropriate dosage forms, with assured quality and adequate information, and at a price the individual and the community can afford.”</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is generally false. While fixed-dose combinations (FDCs) can be beneficial in certain scenarios (like in the treatment of HIV/AIDS or tuberculosis), they are not universally preferred over single-drug formulations. The preference for FDCs or single drugs depends on several factors, including the therapeutic context, the risk of drug-drug interactions, patient adherence, and the potential for resistance development. Mostly, single drugs are preferred due to their flexibility in dosing and the ability to adjust individual components based on patient needs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Adequate safety profile needs to be established</strong>: This is true. When selecting essential drugs, it's crucial that they have a well-established safety profile. Safety is a key consideration to ensure that the benefits of a drug outweigh its risks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Cost to benefit has to be considered</strong>: This is also true. In the selection of essential drugs, the cost-effectiveness of a drug is an important factor. The aim is to provide the most effective treatment at the lowest possible cost.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Disease prevalence is considered</strong>: This is true. When selecting essential drugs, the prevalence of diseases in a population is an important consideration. Drugs to treat common and life-threatening diseases are typically prioritized.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The selection of essential drugs prioritizes factors like safety, cost-effectiveness, and disease prevalence. Fixed-dose combinations are not universally preferred over single drugs, as the choice depends on specific therapeutic needs and other considerations.</span></p>",
      "correct_choice_id": 28170,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6525,
      "choices": [
        {
          "id": 26069,
          "text": "<p><span style=\"font-size:12.0pt;\">DNA gyrase inhibition</span></p>"
        },
        {
          "id": 26070,
          "text": "<p><span style=\"font-size:12.0pt;\">Ribosomal inhibition</span></p>"
        },
        {
          "id": 26071,
          "text": "<p><span style=\"font-size:12.0pt;\">Cell wall synthesis inhibition</span></p>"
        },
        {
          "id": 26072,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of folic acid synthesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman presenting with symptoms of urinary tract infection was prescribed a drug that causes tendon rupture and arthropathy. What is the mechanism of action of the drug? (NEET PG 2022)</span></p>",
      "unique_key": "Q4043804",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993506,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) DNA gyrase inhibition</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The description of a drug causing tendon rupture and arthropathy, especially in the context of treating a urinary tract infection, points towards a fluoroquinolone antibiotic. Fluoroquinolones, such as ciprofloxacin, work by inhibiting bacterial DNA gyrase and topoisomerase IV, which are essential for bacterial DNA replication and transcription.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ribosomal Inhibition:</strong> Antibiotics that inhibit ribosomes, such as macrolides, tetracyclines, and aminoglycosides, affect protein synthesis. These drugs are not typically associated with tendon rupture or arthropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cell Wall Synthesis Inhibition</strong>: Drugs that inhibit cell wall synthesis, like beta-lactams (penicillins, cephalosporins) and vancomycin, are not known to cause tendon rupture or arthropathy as a common side effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Inhibition of Folic Acid Synthesis</strong>: Antibiotics that inhibit folic acid synthesis, such as sulfonamides and trimethoprim, do not typically cause tendon rupture or arthropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fluoroquinolones, which inhibit DNA gyrase and topoisomerase IV, are associated with serious side effects such as tendon rupture and arthropathy.</span></p>",
      "correct_choice_id": 26069,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6440,
      "choices": [
        {
          "id": 25729,
          "text": "<p><span style=\"font-size:12.0pt;\">Asthma</span></p>"
        },
        {
          "id": 25730,
          "text": "<p><span style=\"font-size:12.0pt;\">Peptic ulcer disease</span></p>"
        },
        {
          "id": 25731,
          "text": "<p><span style=\"font-size:12.0pt;\">Glaucoma</span></p>"
        },
        {
          "id": 25732,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following conditions can be treated with pirenzepine?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q4844987",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993500,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Peptic ulcer disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The M1 muscarinic receptors in the stomach increase the acid secretion. Pirenzepine is an M1 blocker, which can help in reducing the acid secretion and thereby was used in the treatment of peptic ulcer disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Asthma: </strong>Asthma is typically treated with bronchodilators (e.g., beta-agonists) and anti-inflammatory drugs (e.g., corticosteroids). Pirenzepine is not used in the treatment of asthma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Glaucoma: </strong>Glaucoma is often treated with medications that reduce intraocular pressure, such as beta-blockers, prostaglandin analogs, or carbonic anhydrase inhibitors. Pirenzepine is not indicated for the treatment of glaucoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hypertension: </strong>Hypertension is treated with a variety of medications including diuretics, ACE inhibitors, beta-blockers, calcium channel blockers, and others. Pirenzepine is not used in the management of hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pirenzepine is an M1 muscarinic receptor antagonist that reduces gastric acid secretion and is used in the treatment of peptic ulcer disease. It is not indicated for conditions such as asthma, glaucoma, or hypertension.</span></p>",
      "correct_choice_id": 25730,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6524,
      "choices": [
        {
          "id": 26065,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin E</span></p>"
        },
        {
          "id": 26066,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin K</span></p>"
        },
        {
          "id": 26067,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B6</span></p>"
        },
        {
          "id": 26068,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young patient began taking a weight loss medication that works by preventing fat absorption from food. She developed easy bruising and increased menstrual bleeding after a few weeks. Which of the following vitamins deficiency is likely to be responsible for her condition? (NEET PG 2022)</span></p>",
      "unique_key": "Q7651343",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993450,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Vitamin K</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Vitamin A, D, E and K are fat soluble vitamins. Their absorption is hampered when the absorption of fat is prevented by a medication (eg Orlistat , Ezetimibe etc).</span></li><li><span style=\"font-size:12.0pt;\">Vitamin K is required for the Gamma carboxylation of Glutamic acid residues of clotting factors 2 ,7 ,9 and 10 in order to activate them. If Vitamin K is deficient due to fat malabsorption, as in the above case, then there can be bleeding manifestations in the form of easy bruising and increased menstrual bleeding in females. The Prothrombin Time (PT) will be elevated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Vitamin E:&nbsp;</strong>Vitamin E deficiency can manifest as hemolytic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vitamin B6:&nbsp;</strong>Vitamin B6 deficiency can be seen with drugs like Isoniazid, Penicillamine, Hydralazine, OCP. Patients can have peripheral neuritis, lowered seizure threshold, or convulsions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vitamin D:</strong> Vitamin D deficiency leads to the development of rickets in children and osteomalacia in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vitamin K deficiency due to impaired fat absorption from weight loss medications can lead to bleeding manifestations such as easy bruising and increased menstrual bleeding.</span></p>",
      "correct_choice_id": 26066,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6483,
      "choices": [
        {
          "id": 25901,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiazide inhibits the metabolism of lithium</span></p>"
        },
        {
          "id": 25902,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiazides act as an add-on drug to lithium</span></p>"
        },
        {
          "id": 25903,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiazides increase the tubular resorption of lithium</span></p>"
        },
        {
          "id": 25904,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiazides cause water loss thereby increasing lithium levels</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male with a long-standing history of bipolar disorder has been stable on lithium therapy. Recently, he was diagnosed with hypertension and started on thiazide diuretics. After a few days, he presented with coarse tremors and other symptoms suggestive of lithium toxicity. What is the likely mechanism of this interaction between lithium and thiazides?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2020)</span></p>",
      "unique_key": "Q3652678",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993504,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Thiazides increase the tubular resorption of lithium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thiazides reduce the excretion of sodium in the renal tubules. Lithium is reabsorbed in a manner similar to sodium, leading to its increased reabsorption and elevated blood levels, resulting in potential toxicity. In this clinical case, the patient's symptoms of lithium toxicity are most likely due to the thiazide-induced increase in tubular reabsorption of lithium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Thiazide inhibits the metabolism of lithium:</strong> Lithium is primarily excreted unchanged by the kidneys, not metabolized. Thiazides don't affect lithium's metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Thiazides act as an add-on drug to lithium:</strong> There's no evidence that thiazides synergistically increase the toxic or therapeutic effects of lithium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Thiazides cause water loss thereby increasing lithium levels:</strong> Thiazides do act as diuretics, but the primary mechanism of increasing lithium levels is through enhanced tubular reabsorption rather than water loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thiazide diuretics increase the tubular reabsorption of lithium, leading to elevated blood levels and potential toxicity. This interaction is crucial to consider when prescribing thiazides to patients on lithium therapy.</span></p>",
      "correct_choice_id": 25903,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13989,
      "choices": [
        {
          "id": 55917,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac tamponade</span></p>"
        },
        {
          "id": 55918,
          "text": "<p><span style=\"font-size:12.0pt;\">Tension pneumothorax</span></p>"
        },
        {
          "id": 55919,
          "text": "<p><span style=\"font-size:12.0pt;\">Pericardial effusion</span></p>"
        },
        {
          "id": 55920,
          "text": "<p><span style=\"font-size:12.0pt;\">Massive hemothorax</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old female victim of RTA presents to the ER. On examination, GCS is 15/15, heart rate = 110/min, BP = 90/60 mmHg, and there is elevated JVP. The right chest is tympanic on percussion with decreased breath sounds on auscultation. The left chest appears normal. But the patient is dyspneic and ecchymosis is noted over the chest wall. The abdomen is soft. The probable diagnosis is: (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q2782176",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993505,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Tension Pneumothorax</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical scenario of hemodynamic instability, tympanic note (hyper-resonant) on percussion, and decreased breath sounds on the affected side is suggestive of tension pneumothorax.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tension pneumothorax occurs when air accumulates in the pleural space and cannot escape, leading to increased pressure in the chest cavity. This condition can compress the lungs and the great vessels in the chest, causing respiratory distress, hypotension, elevated JVP, and decreased breath sounds on auscultation. Tympanic percussion note over the right chest is consistent with air in the pleural space. Ecchymosis (bruising) over the chest wall can result from trauma and rib fractures associated with tension pneumothorax.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Cardiac tamponade</strong>: Cardiac tamponade typically presents with symptoms such as hypotension, muffled heart sounds, and distended neck veins (Jugular Venous Pressure - JVP). While elevated JVP is mentioned in the scenario, the other symptoms associated with cardiac tamponade, such as muffled heart sounds and hypotension, are not present.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Pericardial effusion</strong>: Pericardial effusion involves the accumulation of fluid around the heart. While it can cause elevated JVP, it typically presents with other cardiac symptoms, such as muffled heart sounds and chest pain. The scenario does not mention these cardiac-specific symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Massive hemothorax</strong>: Massive hemothorax refers to a significant accumulation of blood in the pleural space. It can cause decreased breath sounds, but it is not typically associated with a tympanic percussion note or elevated JVP unless there is concurrent tension pneumothorax.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A tension pneumothorax develops when there is a tear is either in the parietal or visceral pleura. This tear acts as a one-way valve i.e., air enters from the lung or chest wall through it during inspiration but has no way to escape during expiration. This ultimately causes collapse of the affected lung.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>It is characterized by:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Chest pain</span></li><li><span style=\"font-size:12.0pt;\">Tachypnoea, and acute dyspnea</span></li><li><span style=\"font-size:12.0pt;\">Sudden onset hemodynamic compromise (tachycardia, hypotension, low O2 saturation, loss of consciousness)</span></li><li><span style=\"font-size:12.0pt;\">Neck vein distention</span></li><li><span style=\"font-size:12.0pt;\">Tracheal deviation away from the side of injury</span></li><li><span style=\"font-size:12.0pt;\">Decreased chest movements on the affected side</span></li><li><span style=\"font-size:12.0pt;\">Hyper-resonance on percussion on the affected side</span></li><li><span style=\"font-size:12.0pt;\">Absence or decreased breath sounds on the affected side</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tension pneumothorax is a clinical diagnosis, and treatment must never be delayed waiting for radiological confirmation. Management includes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Immediate management:&nbsp;</strong>Needle decompression or needle thoracostomy i.e. insertion of a wide-bore needle in the 5th ICS anterior to the midaxillary line. In the pediatric age group, the needle thoracostomy location is at the 2nd ICS midclavicular line.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Definitive management:&nbsp;</strong>Tube thoracostomy or chest tube insertion in the 5th ICS in the triangle of safety.</span></li></ul>",
      "correct_choice_id": 55918,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31805,
      "choices": [
        {
          "id": 127090,
          "text": "<p><span style=\"font-size:12pt;\">Tacrolimus</span></p>"
        },
        {
          "id": 127091,
          "text": "<p><span style=\"font-size:12pt;\">Nifedipine</span></p>"
        },
        {
          "id": 127092,
          "text": "<p><span style=\"font-size:12pt;\">Diltiazem</span></p>"
        },
        {
          "id": 127093,
          "text": "<p><span style=\"font-size:12pt;\">Verapamil</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following drugs is an inhibitor of ATP binding cassette efflux pumps? (INICET NOV 2023)</span></p>",
      "unique_key": "Q6250504",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993452,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Verapamil</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Verapamil is known to inhibit the activity of ATP-binding cassette (ABC) transporters, such as P-glycoprotein, which is one of the most well-studied drug efflux transporters. By inhibiting P-glycoprotein, verapamil can increase the intracellular concentration of various drugs, which is why it is sometimes used as a pharmacokinetic enhancer to improve drug absorption and decrease drug clearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Tacrolimus:</strong> Tacrolimus is an immunosuppressant drug used mainly after allogeneic organ transplant to reduce the activity of the patient's immune system and lower the risk of organ rejection. It is not an inhibitor of the ATP-binding cassette efflux transporters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Nifedipine:</strong> Nifedipine is a calcium channel blocker used primarily to treat hypertension and angina pectoris. It is not known to inhibit ABC efflux transporters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Diltiazem:</strong> Diltiazem, like verapamil, is a calcium channel blocker, but it is not as potent as verapamil in inhibiting P-glycoprotein. However, it does have some effect on drug efflux transporters, but to a lesser extent compared to verapamil.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Verapamil is a known inhibitor of ATP-binding cassette transporters, particularly P-glycoprotein, and can be used to enhance the pharmacokinetics of various drugs by increasing their intracellular concentrations.</span></p>",
      "correct_choice_id": 127093,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 64641,
      "choices": [
        {
          "id": 257761,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3 and 4</span></p>"
        },
        {
          "id": 257762,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3 and 5</span></p>"
        },
        {
          "id": 257763,
          "text": "<p><span style=\"font-size:12.0pt;\">3, 4 and 5</span></p>"
        },
        {
          "id": 257764,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4 and 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Aspirin and phenobarbitone are acidic drugs, whereas diazepam is a basic drug. Which of the following statement/s about these drugs is/are true? <i>(Twisted PYQ)</i></span></p><ol><li><span style=\"font-size:12.0pt;\">Aspirin is mostly ionized in the stomach and thus poorly absorbed.</span></li><li><span style=\"font-size:12.0pt;\">Diazepam is absorbed from the stomach due to its high lipid solubility.</span></li><li><span style=\"font-size:12.0pt;\">Phenobarbitone absorption occurs mainly in the small intestine due to its large surface area.</span></li><li><span style=\"font-size:12.0pt;\">Drugs can be absorbed in the large intestine, although to a lesser extent than the small intestine.</span></li><li><span style=\"font-size:12.0pt;\">Diseases decreasing the transit time of drugs, like diarrhea, will decrease drug absorption in the small intestine.</span></li></ol>",
      "unique_key": "Q5468244",
      "question_audio": null,
      "question_video": null,
      "map_id": 15173099,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. 3, 4 and 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The absorption of drugs depends on the non-ionized, lipid-soluble form of the drug, which crosses membranes more efficiently.</span></p><ol><li><span style=\"font-size:12.0pt;\"><strong>Phenobarbitone absorption occurs mainly in the small intestine due to its large surface area (True)</strong>: Like most drugs, phenobarbitone absorption is maximized in the small intestine, where the surface area for absorption is far greater than in the stomach.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Drugs can be absorbed in the large intestine (True)</strong>: Although the surface area of the large intestine is smaller than that of the small intestine, it can still absorb drugs. This is particularly relevant for sustained-release formulations or drugs undergoing enterohepatic recycling.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Diseases decreasing transit time (True)</strong>: Conditions like diarrhea reduce the time available for drug absorption in the intestine, leading to reduced absorption.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Incorrect Options:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Aspirin is mostly ionized in the stomach (False)</strong>: Aspirin, an acidic drug, remains largely non-ionized in the stomach and is capable of being absorbed there. However, its absorption is limited due to the short gastric emptying time.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Diazepam is absorbed in the stomach (False)</strong>: Diazepam, a basic drug, becomes non-ionized in the alkaline pH of the intestine, where its lipid solubility facilitates maximal absorption.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture1_Tc06qmP.png\" width=\"602\" height=\"262\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Drug absorption depends on the physicochemical properties of the drug (acidic or basic), the pH of the gastrointestinal tract, and the surface area available. Most absorption occurs in the small intestine due to its large surface area, irrespective of the drug's acidic or basic nature. Transit time significantly impacts absorption, with shorter times, such as in diarrhea, reducing drug absorption.</span></p>",
      "correct_choice_id": 257763,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57285,
      "choices": [
        {
          "id": 228521,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Physostigmine</span></span></p>"
        },
        {
          "id": 228522,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rivastigmine</span></span></p>"
        },
        {
          "id": 228523,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sugammadex</span></span></p>"
        },
        {
          "id": 228524,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Succinylcholine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with mild to moderate renal failure requires reversal of muscle relaxation induced by vecuronium. Which of the following drugs is appropriate for this purpose? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q4861888",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055230,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Sugammadex</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vecuronium is a non-depolarizing muscle relaxant used during surgeries to facilitate intubation and muscle relaxation. After the procedure, it is often necessary to reverse the effects of vecuronium to allow the patient to regain muscle function. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sugammadex is a selective relaxant binding agent (SRBA) specifically designed to reverse the effects of certain non-depolarizing muscle relaxants, including vecuronium and rocuronium. It works by encapsulating the vecuronium molecules, effectively reducing their availability to bind to nicotinic receptors at the neuromuscular junction, thereby reversing muscle paralysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sugammadex is preferred in patients with mild to moderate renal failure because it is highly effective and works faster than traditional agents like neostigmine. While Sugammadex is contraindicated in severe or end-stage renal disease due to reduced clearance, it can be safely used in mild to moderate renal impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note &ndash; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reversal agents for muscle relaxants used in anesthesia include neostigmine and Sugammadex.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neostigmine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A cholinergic drug that inhibits acetylcholinesterase, leading to increased acetylcholine.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Causes cholinergic side effects due to the increased acetylcholine.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Can be used for all muscle relaxants.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Can be given in renal disease patients </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If neostigmine is not an option and the patient has mild to moderate renal failure, Sugammadex is the preferred choice.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Physostigmine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Physostigmine is an acetylcholinesterase inhibitor, but it is primarily used to reverse the effects of central nervous system depressants and is not typically used for reversing non-depolarizing muscle relaxants like vecuronium.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Rivastigmine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Rivastigmine is also an acetylcholinesterase inhibitor, but it is used in the management of Alzheimer&#39;s disease and other types of dementia, not for reversing muscle relaxants.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Succinylcholine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Succinylcholine is a depolarizing muscle relaxant used for short-term muscle relaxation, such as during intubation. It is not used for reversing the effects of non-depolarizing muscle relaxants like vecuronium and, in fact, would induce more muscle relaxation rather than reverse it.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sugammadex is the appropriate agent for reversing the effects of vecuronium in patients with mild to moderate renal failure due to its specific action on non-depolarizing muscle relaxants and its faster onset of action.</span></span></span></p>",
      "correct_choice_id": 228523,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 64645,
      "choices": [
        {
          "id": 257777,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 257778,
          "text": "<p><span style=\"font-size:12.0pt;\">Bisoprolol</span></p>"
        },
        {
          "id": 257779,
          "text": "<p><span style=\"font-size:12.0pt;\">Pindolol</span></p>"
        },
        {
          "id": 257780,
          "text": "<p><span style=\"font-size:12.0pt;\">Carvedilol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following beta-blockers is contraindicated in patients with congestive heart failure due to its intrinsic sympathomimetic activity (ISA)? (Twisted PYQ)</span></p>",
      "unique_key": "Q7638170",
      "question_audio": null,
      "question_video": null,
      "map_id": 15173103,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Pindolol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Pindolol is a non-selective beta-blocker with intrinsic sympathomimetic activity (ISA). Beta-blockers with ISA are generally contraindicated in heart failure as they can stimulate beta receptors, counteracting the benefits of beta blockade. This can increase myocardial workload and exacerbate heart failure, making pindolol unsuitable for these patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Propranolol:</strong> Propranolol is a non-selective beta-blocker but lacks ISA. While it is not preferred in heart failure management, it is not contraindicated like pindolol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Bisoprolol:</strong> Bisoprolol is a cardioselective beta-blocker approved for use in heart failure. It decreases mortality by reducing sympathetic activation and improving heart function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Carvedilol:</strong> Carvedilol is a non-selective beta-blocker with additional alpha-blocking effects. It is highly effective in CHF management and has been proven to reduce mortality.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Beta-blockers with intrinsic sympathomimetic activity, such as pindolol, are contraindicated in heart failure due to their ability to increase myocardial workload. Preferred beta-blockers for CHF management include bisoprolol, carvedilol, and metoprolol, which reduce mortality by improving cardiac function and limiting sympathetic overdrive.</span></p>",
      "correct_choice_id": 257779,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6424,
      "choices": [
        {
          "id": 25665,
          "text": "<p><span style=\"font-size:12.0pt;\">Angiotensin Il inhibitor</span></p>"
        },
        {
          "id": 25666,
          "text": "<p><span style=\"font-size:12.0pt;\">ACE inhibitor</span></p>"
        },
        {
          "id": 25667,
          "text": "<p><span style=\"font-size:12.0pt;\">Renin inhibitor</span></p>"
        },
        {
          "id": 25668,
          "text": "<p><span style=\"font-size:12.0pt;\">Neutral endopeptidase inhibitor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Sacubitril is a new drug approved for chronic heart failure. The mechanism of action of Sacubitril is?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q8181962",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055163,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Neutral endopeptidase inhibitor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sacubitril is a Neprilysin inhibitor (Neutral Endopeptidase inhibitor). Neprilysin is the enzyme that metabolizes Atrial Natriuretic Peptide, Substance P, Bradykinin, Adrenomedullin and Angiotensin II. It is used in a 1:1 ratio with Valsartan (Angiotensin Receptor Blocker), thereby increasing the levels of the other substances which helps in decreasing the blood pressure in a patient of chronic heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Angiotensin II inhibitor:&nbsp;</strong>Sacubitril does not directly inhibit angiotensin II. However, valsartan, which is combined with sacubitril in the fixed-dose combination, blocks the effects of angiotensin II at its receptor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. ACE inhibitor:&nbsp;</strong>Sacubitril is not an ACE inhibitor. ACE inhibitors work by inhibiting the angiotensin-converting enzyme, which decreases the production of angiotensin II. Sacubitril, on the other hand, inhibits neprilysin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Renin inhibitor:&nbsp;</strong>Sacubitril is not a renin inhibitor. Renin inhibitors, such as aliskiren, work by directly inhibiting renin, an enzyme involved in the RAAS pathway.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sacubitril is a neprilysin (neutral endopeptidase) inhibitor used in combination with valsartan to treat chronic heart failure. By inhibiting neprilysin, sacubitril increases the levels of natriuretic peptides and other vasoactive substances, leading to beneficial cardiovascular effects.</span></p>",
      "correct_choice_id": 25668,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7122,
      "choices": [
        {
          "id": 28456,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Causes monofollicular development</span></span></span></p>"
        },
        {
          "id": 28457,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inhibits negative feedback on GnRH</span></span></span></p>"
        },
        {
          "id": 28458,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Causes endometrial thinning</span></span></span></p>"
        },
        {
          "id": 28459,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Can be used with gonadotropins</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the incorrect statement regarding clomiphene citrate? (INICET MAY 2021)</span></span></p>",
      "unique_key": "Q6177632",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993449,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Causes monofollicular development</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clomiphene citrate is SERM (Selective Estrogen Receptor Modulator) that inhibits the negative feedback of estrogen on the hypothalamus, which in turn leads to an increase in LH/FSH, and this helps in the development of multiple follicles in the ovary. Clomiphene is used in the treatment of anovulatory infertility.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Due to its anti-estrogenic action over the endometrium, it causes thickening of the cervical mucus and thinning of the endometrium.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sometimes for ovulation induction, gonadotropins can be used with clomiphene, but it has a risk of giving rise to multiple pregnancy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Inhibits negative feedback on GnRH: </span></strong><span style=\"font-size:12.0pt\">This statement is correct. Clomiphene citrate inhibits the negative feedback of estrogen on the hypothalamus, which increases the release of GnRH, and subsequently increases LH and FSH secretion from the pituitary gland.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Causes endometrial thinning: </span></strong><span style=\"font-size:12.0pt\">This statement is correct. Clomiphene citrate has an anti-estrogenic effect on the endometrium, which can lead to thinning of the endometrial lining, potentially impacting embryo implantation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Can be used with gonadotropins: </span></strong><span style=\"font-size:12.0pt\">This statement is correct. Clomiphene can be used in combination with gonadotropins for ovulation induction, but this approach increases the risk of multiple pregnancies due to the stimulation of multiple follicles.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clomiphene citrate induces ovulation by inhibiting the negative feedback of estrogen on the hypothalamus, leading to increased secretion of gonadotropins and the development of multiple follicles. It can cause endometrial thinning and can be used with gonadotropins, but it does not cause monofollicular development.</span></span></span></p>",
      "correct_choice_id": 28456,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33866,
      "choices": [
        {
          "id": 135302,
          "text": "<p><span style=\"font-size:12.0pt;\">Clopidogrel</span></p>"
        },
        {
          "id": 135303,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin</span></p>"
        },
        {
          "id": 135304,
          "text": "<p><span style=\"font-size:12.0pt;\">Betrixaban</span></p>"
        },
        {
          "id": 135305,
          "text": "<p><span style=\"font-size:12.0pt;\">Enoxaparin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A pregnant female in first trimester developed deep vein thrombosis. She requires anticoagulation. Which of the following will be the preferred drug in this patient?</span> <span style=\"font-size:12.0pt;\">(Fmge Jan 2024)</span></p>",
      "unique_key": "Q7688670",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055159,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D. Enoxaparin</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Enoxaparin is the preferred drug for a pregnant female with DVT, particularly in the first trimester. Its safety profile and effectiveness in treating and preventing DVT make it suitable for use in pregnancy. The other options either have safety concerns during pregnancy or are not typically used for the treatment of DVT.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.</strong> <strong>Clopidogrel:</strong> This is an antiplatelet drug, not typically used in the treatment of DVT, and its safety in pregnancy is not well-established.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Warfarin:</strong> Warfarin is a vitamin K antagonist and is generally contraindicated in pregnancy, especially during the first trimester, due to the risk of teratogenic effects (warfarin embryopathy).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong> <strong>Betrixaban:</strong> This is an oral Factor Xa inhibitor. The safety of betrixaban in pregnancy has not been established, and it is generally not recommended.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Enoxaparin, a low molecular weight heparin (LMWH) is the preferred choice for anticoagulation in pregnancy because they do not cross the placenta and thus have a lower risk of fetal harm. Enoxaparin is effective in the treatment and prevention of DVT and is considered safe for use in pregnancy.</span></p>",
      "correct_choice_id": 135305,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31804,
      "choices": [
        {
          "id": 127086,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ethyl alcohol </span></span></p>"
        },
        {
          "id": 127087,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Flumazenil </span></span></p>"
        },
        {
          "id": 127088,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Diazepam </span></span></p>"
        },
        {
          "id": 127089,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Naloxone</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A person purchased two bottles of alcohol from a local liquor store and subsequently developed symptoms of drowsiness, blurred vision, and ataxia. What is the appropriate antidote for treatment? &nbsp;(Fmge July 2023)</span></span></p>",
      "unique_key": "Q3118495",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055153,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans</strong><strong>.</strong><strong> A) Ethyl alcohol</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ethyl alcohol (ethanol) is the correct antidote in this scenario, where the symptoms of drowsiness, blurred vision, and ataxia suggest methanol poisoning, potentially from adulterated alcohol. Ethanol acts by competing with methanol for the enzyme alcohol dehydrogenase, which slows down the conversion of methanol into its toxic metabolites, formaldehyde and formic acid.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Note:</strong> Now, the antidote of choice for methanol poisoning is fomepizole.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Flumazenil:</strong> Flumazenil is an antidote for benzodiazepine overdose. It is not effective in methanol poisoning, as the symptoms and underlying toxicological mechanisms are different.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Diazepam:</strong> Diazepam is a benzodiazepine and would not be an appropriate antidote for methanol poisoning. In fact, using diazepam in this context could exacerbate central nervous system depression.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Naloxone:</strong> Naloxone is an opioid antagonist used in opioid overdose cases. It is not effective against the toxic effects of methanol and would not be appropriate in this situation.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective: </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ethyl alcohol (ethanol) is used as an antidote in methanol poisoning because it competes with methanol for the enzyme alcohol dehydrogenase, thus preventing the formation of toxic metabolites.</span></span></p>",
      "correct_choice_id": 127086,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6496,
      "choices": [
        {
          "id": 25953,
          "text": "<p><span style=\"font-size:12.0pt;\">5-Fluorouracil</span></p>"
        },
        {
          "id": 25954,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampicin</span></p>"
        },
        {
          "id": 25955,
          "text": "<p><span style=\"font-size:12.0pt;\">Nitrofurantoin</span></p>"
        },
        {
          "id": 25956,
          "text": "<p><span style=\"font-size:12.0pt;\">Novobiocin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an inhibitor of RNA synthesis? (NEET PG 2020)</span></p>",
      "unique_key": "Q9511102",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993843,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Rifampicin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Among the options mentioned above, Rifampicin is the drug that acts by blocking RNA polymerase enzyme. It is one of the 1<sup>st</sup> line Anti Tubercular and anti-Leprosy drugs. It has the bactericidal effect against the mycobacteria, that are present both intracellularly as well as extracellularly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 5-Fluorouracil</strong>: This is an anticancer drug that primarily inhibits thymidylate synthase, affecting DNA synthesis rather than specifically inhibiting RNA synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Nitrofurantoin</strong>: This drug is primarily used for treating urinary tract infections. It does inhibit bacterial DNA, RNA, and protein synthesis but is not specifically an inhibitor of RNA synthesis alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Novobiocin</strong>: This antibiotic inhibits DNA gyrase, an enzyme involved in DNA supercoiling, but it does not inhibit RNA synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-105712.png\" alt=\"\" width=\"1000\" height=\"309\"></p>",
      "correct_choice_id": 25954,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6475,
      "choices": [
        {
          "id": 25869,
          "text": "<p><span style=\"font-size:12.0pt;\">Meropenem</span></p>"
        },
        {
          "id": 25870,
          "text": "<p><span style=\"font-size:12.0pt;\">Imipenem</span></p>"
        },
        {
          "id": 25871,
          "text": "<p><span style=\"font-size:12.0pt;\">Cefazolin</span></p>"
        },
        {
          "id": 25872,
          "text": "<p><span style=\"font-size:12.0pt;\">Piperacillin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Cilastatin is administered to prolong the action of which of the following drugs? (NEET PG 2019)</span></p>",
      "unique_key": "Q7369296",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993842,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Imipenem</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Imipenem is a carbapenem that is broken down by the enzyme dehydropeptidase in the kidney. Cilastatin is therefore administered along with it, which is an inhibitor of dehydropeptidase, thereby it prolongs the action of Imipenem.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Meropenem: </strong>Meropenem is another carbapenem antibiotic, but it is not significantly degraded by renal dehydropeptidase I and does not require co-administration with cilastatin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cefazolin: </strong>Cefazolin is a first-generation cephalosporin antibiotic that is not affected by renal dehydropeptidase I and does not require cilastatin for its administration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Piperacillin: </strong>Piperacillin is a broad-spectrum penicillin antibiotic, and its activity is not influenced by renal dehydropeptidase I, thus not requiring cilastatin for its administration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cilastatin is specifically administered with imipenem to inhibit renal dehydropeptidase I, preventing the breakdown of imipenem and thereby prolonging its action in the body.</span></p>",
      "correct_choice_id": 25870,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6495,
      "choices": [
        {
          "id": 25949,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of xanthine oxidase</span></p>"
        },
        {
          "id": 25950,
          "text": "<p><span style=\"font-size:12.0pt;\">Conversion of uric acid to allantoin</span></p>"
        },
        {
          "id": 25951,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase excretion of uric acid</span></p>"
        },
        {
          "id": 25952,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of granulocyte migration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old male patient with chronic gout is under consideration for a change in treatment plan due to poor response to conventional therapies like allopurinol and colchicine. The healthcare team is discussing the potential use of pegloticase. What is the mechanism of action of pegloticase?\" (NEET PG 2020)</span></p>",
      "unique_key": "Q4462192",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055158,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Conversion of uric acid to allantoin.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pegloticase is a recombinant uricase enzyme that converts uric acid into allantoin, which is more soluble and easier to excrete through the kidneys. This action helps to lower high levels of uric acid in patients with chronic gout who have not responded well to conventional therapies such as allopurinol and colchicine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Inhibition of xanthine oxidase</strong>: This is the mechanism of action for allopurinol, not pegloticase. Allopurinol inhibits xanthine oxidase, which is an enzyme involved in the conversion of hypoxanthine and xanthine to uric acid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Increase excretion of uric acid</strong>: Some medications like probenecid work by this mechanism to increase the renal excretion of uric acid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Inhibition of granulocyte migration</strong>: Colchicine works through inhibiting granulocyte migration, but pegloticase primarily works by metabolizing uric acid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pegloticase works by converting uric acid to allantoin, a more soluble compound that is easily excreted by the kidneys. This mechanism is distinct from other gout treatments and is particularly useful for patients with refractory chronic gout.</span></p>",
      "correct_choice_id": 25950,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24713,
      "choices": [
        {
          "id": 98813,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of angiogenesis</span></p>"
        },
        {
          "id": 98814,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in IL-2, IL-4 and IL-5</span></p>"
        },
        {
          "id": 98815,
          "text": "<p><span style=\"font-size:12.0pt;\">Generation of oxygen free radicals</span></p>"
        },
        {
          "id": 98816,
          "text": "<p><span style=\"font-size:12.0pt;\">Binding to cereblon</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Mechanism of thalidomide teratogenicity include all except</span></p>",
      "unique_key": "Q1834330",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055166,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Increase in IL-2, IL-4 and IL-5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thalidomide actually suppresses the production of certain cytokines, including IL-2, IL-4, and IL-5. The suppression of these interleukins is part of its immunomodulatory effects, not a mechanism of teratogenicity. Thalidomide suppresses the production of interleukins which is an important mechanism in treatment of multiple myeloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The exact mechanism of thalidomide's teratogenicity is not completely understood, but several mechanisms have been proposed:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Inhibition of angiogenesis</strong>: Thalidomide has been found to inhibit angiogenesis, which is the formation of new blood vessels. This inhibition can disrupt the development of the fetus, leading to birth defects. This mechanism is widely accepted as a significant contributor to the teratogenic effects of thalidomide.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Generation of oxygen free radicals</strong>: Thalidomide may cause oxidative stress by generating oxygen free radicals, which can damage developing cells. This oxidative stress can contribute to teratogenic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Binding to cereblon</strong>: Recent studies have shown that thalidomide binds to a protein called cereblon, which is involved in limb outgrowth and ear development. When thalidomide binds to cereblon, it disrupts the normal function of this protein, leading to the birth defects associated with thalidomide use.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Other mechanism includes -</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Interference with cellular signalling:</strong> Thalidomide may interfere with various cellular signalling pathways, such as those involving fibroblast growth factors, which are important for embryonic development.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thalidomide's teratogenicity is primarily associated with mechanisms such as the inhibition of angiogenesis, generation of oxygen free radicals, and binding to the cereblon protein. It does not cause an increase in IL-2, IL-4, and IL-5; in fact, it suppresses these interleukins.</span></p>",
      "correct_choice_id": 98814,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6505,
      "choices": [
        {
          "id": 25989,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol</span></p>"
        },
        {
          "id": 25990,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium channel blockers</span></p>"
        },
        {
          "id": 25991,
          "text": "<p><span style=\"font-size:12.0pt;\">Angiotensin-converting enzyme inhibitors</span></p>"
        },
        {
          "id": 25992,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha methyldopa</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old chronic hypertensive woman visits the outpatient department for pre-conceptional counseling. Which of the following anti-hypertensive should she discontinue? (NEET PG 2021)</span></p>",
      "unique_key": "Q2018825",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993844,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Angiotensin-converting enzyme inhibitors</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These medications are contraindicated during pregnancy because they are associated with fetal renal dysplasia, oligohydramnios, and other congenital anomalies. Therefore, women who are planning to conceive should discontinue these medications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Labetalol</strong>: Labetalol is generally safe for use during pregnancy and is a treatment option for hypertension in pregnant women. It is not necessary to discontinue this medication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Calcium channel blockers</strong>: Calcium channel blockers like nifedipine are also generally considered safe during pregnancy and are often used to manage hypertension in pregnant women.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Alpha methyldopa</strong>: Alpha methyldopa is also considered safe during pregnancy and is commonly used for managing hypertension in this population.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given the woman's intention to conceive, discontinuing Angiotensin-converting enzyme inhibitors would be the most appropriate course of action to protect both her health and that of her future child.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ACE inhibitors should be discontinued in women who are planning to conceive due to their associated risks of fetal renal dysplasia, oligohydramnios, and other congenital anomalies. Alternative antihypertensive medications that are safer during pregnancy include labetalol, calcium channel blockers, and alpha methyldopa.</span></p>",
      "correct_choice_id": 25991,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9770,
      "choices": [
        {
          "id": 39047,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Philadelphia chromosome</span></span></span></p>"
        },
        {
          "id": 39048,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">JAK mutation</span></span></span></p>"
        },
        {
          "id": 39049,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythropoietin levels</span></span></span></p>"
        },
        {
          "id": 39050,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bone Marrow biopsy with reticulin stain</span></span></span></p>"
        }
      ],
      "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A young boy from high altitude came with fever and weakness and had the following reports Hemoglobin 17 gm%, TLC is 21,000 with neutrophils 25, lymphocytes 30, eosinophils 5, myelocytes and metamyelocytes 40 in peripheral smear. Next step in the investigation should be:&nbsp;</span></span></span>(AIIMS MAY 2019)</p>",
      "unique_key": "Q3753095",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993503,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Erythropoietin levels</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The given clinical scenario is suggestive of polycythemia (Hb&gt;16 g/dL). Erythropoietin levels should be determined to differentiate primary from secondary forms.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Polycythemia vera (PCV) is characterized by increased marrow production of red cells, granulocytes, and platelets (panmyelosis), but it is the increase in red cells (polycythemia), that is responsible for most of the clinical symptoms. PCV must be differentiated from relative polycythemia resulting from hemoconcentration and other causes of absolute polycythemia. PCV is strongly associated with activating point mutations in the tyrosine kinase JAK2.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In PCV the progenitor cells have markedly decreased requirements for erythropoietin and other hematopoietic growth factors due to constitutive JAK2 signaling. Accordingly, serum erythropoietin levels in PCV are very low, whereas secondary forms of absolute polycythemia have high erythropoietin levels.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-113555.png\" style=\"height:613px; width:1000px\" /></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Philadelphia chromosome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This test is relevant in diagnosing chronic myeloid leukemia (CML), not polycythemia. While the presence of immature myeloid cells (myelocytes and metamyelocytes) could suggest a myeloproliferative disorder, the patient&#39;s clinical presentation and high hemoglobin level are more consistent with polycythemia, making erythropoietin testing a more appropriate next step.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. JAK mutation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Testing for the JAK2 mutation is crucial in confirming a diagnosis of PCV. However, before proceeding to this test, it is important to measure erythropoietin levels to differentiate between primary and secondary polycythemia. If erythropoietin levels are low, JAK2 mutation analysis would then be the next step.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Bone Marrow biopsy with reticulin stain</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This investigation is used to evaluate bone marrow fibrosis, which can occur in myeloproliferative disorders like PCV. However, it is not the first-line investigation in this scenario. The erythropoietin level is a less invasive test that provides critical information to guide further diagnostic steps.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erythropoietin levels should be measured to differentiate between primary and secondary polycythemia. In cases of polycythemia vera, erythropoietin levels are typically low due to constitutive JAK2 signaling, while secondary polycythemia is associated with high erythropoietin levels.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Robbins and Cortans pathologic basis of disease, Pg 1161, 1242</span></strong></span></span></p>",
      "correct_choice_id": 39049,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5338,
      "choices": [
        {
          "id": 21324,
          "text": "<p><span style=\"font-size:12.0pt;\">Timolol</span></p>"
        },
        {
          "id": 21325,
          "text": "<p><span style=\"font-size:12.0pt;\">Apraclonidine</span></p>"
        },
        {
          "id": 21326,
          "text": "<p><span style=\"font-size:12.0pt;\">Latanoprost</span></p>"
        },
        {
          "id": 21327,
          "text": "<p><span style=\"font-size:12.0pt;\">Brimonidine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient presents to ophthalmology clinic with pain in eye. On examination and investigations, it was found to be a case of open angle glaucoma. History of the person reveals that he is also suffering from Bronchial asthma. Which of the following anti glaucoma drug should be avoided in this patient? (Fmge June 2022)</span></p>",
      "unique_key": "Q2678995",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993319,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A. Timolol</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Timolol is a non-selective beta blocker, which means it blocks both beta-1 and beta-2 adrenergic receptors. In patients with bronchial asthma, the blockade of beta-2 receptors can lead to bronchospasm, a potentially severe and life-threatening condition. Therefore, timolol should be avoided in patients with bronchial asthma to prevent exacerbation of their respiratory condition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. Apraclonidine:</strong> Apraclonidine is an alpha agonist. It primarily acts on alpha-2 adrenergic receptors and does not have the bronchoconstrictive effects associated with beta blockers. Therefore, it can be safely used in patients with bronchial asthma.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. Latanoprost:</strong> Latanoprost is a prostaglandin F2α (PGF2) analog. It is the drug of choice for the treatment of primary open angle glaucoma and does not have any bronchoconstrictive properties. It is safe for use in patients with bronchial asthma.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Brimonidine:</strong> Brimonidine is another alpha agonist. Similar to apraclonidine, it acts on alpha-2 adrenergic receptors and does not affect the bronchial smooth muscles. Thus, it is also safe for use in patients with bronchial asthma.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Timolol, a non-selective beta blocker, should be avoided in patients with bronchial asthma due to the risk of precipitating bronchospasm.</span></p>",
      "correct_choice_id": 21324,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6519,
      "choices": [
        {
          "id": 26045,
          "text": "<p><span style=\"font-size:12.0pt;\">IL-6</span></p>"
        },
        {
          "id": 26046,
          "text": "<p><span style=\"font-size:12.0pt;\">IL-2</span></p>"
        },
        {
          "id": 26047,
          "text": "<p><span style=\"font-size:12.0pt;\">IL-4</span></p>"
        },
        {
          "id": 26048,
          "text": "<p><span style=\"font-size:12.0pt;\">IL-5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female with a history of rheumatoid arthritis is not responding well to conventional treatment. Her rheumatologist is considering adding tocilizumab to her treatment regimen. Which of the following interleukins (IL) is primarily targeted by tocilizumab? (NEET PG 2021)</span></p>",
      "unique_key": "Q7349502",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993454,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) IL-6</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Tocilizumab is a monoclonal antibody that specifically targets and inhibits the interleukin-6 (IL-6) receptor. By blocking the IL-6 receptor, tocilizumab interrupts the signaling pathway of IL-6, a cytokine involved in the inflammatory response. This is particularly beneficial in conditions like rheumatoid arthritis, where elevated levels of IL-6 contribute to the inflammatory process.</span></li><li><span style=\"font-size:12.0pt;\">Tocilizumab has also been used in COVID-19 for cytokine release syndrome.</span></li><li><span style=\"font-size:12.0pt;\">It is avoided in patients with liver disease, immunosuppression, having a high risk of GIT perforation, Absolute Neutrophil Count &lt;500 cell/µl and Platelet count &lt;50000 cells/µl.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. IL-2</strong>: Drugs like basiliximab or daclizumab are used to target IL-2 receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. IL-4</strong>: Dupilumab is an example of a medication that targets IL-4.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. IL-5</strong>: Mepolizumab and reslizumab are examples of medications that target IL-5.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tocilizumab targets the IL-6 receptor, making it effective for managing rheumatoid arthritis and certain other inflammatory conditions by inhibiting the IL-6 signaling pathway.</span></p>",
      "correct_choice_id": 26045,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6967,
      "choices": [
        {
          "id": 27836,
          "text": "<p><span style=\"font-size:12pt;\">Prednisolone</span></p>"
        },
        {
          "id": 27837,
          "text": "<p><span style=\"font-size:12pt;\">Salbutamol</span></p>"
        },
        {
          "id": 27838,
          "text": "<p><span style=\"font-size:12pt;\">Fexofenadine</span></p>"
        },
        {
          "id": 27839,
          "text": "<p><span style=\"font-size:12pt;\">Amoxicillin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A known asthmatic patient with fever and sore throat was prescribed an antibiotic. Two days later he presents with a maculopapular rash. Which of the following drugs might have caused this? (INICET NOV 2020)</span></p>",
      "unique_key": "Q5605965",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993316,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Amoxicillin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Out of the options given above, amoxicillin is the only drug which is an antibiotic. It is an amino penicillin. Allergic reactions in the form of skin rashes to Penicillin group of antibiotics are very common, out of which it is the highest with aminopenicillins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options A.</strong>&nbsp;<strong>Prednisolone</strong>: This is a corticosteroid used in the treatment of asthma to reduce inflammation. Corticosteroids like prednisolone are not typically associated with causing maculopapular rashes. In fact, they are often used to treat allergic reactions and rashes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options B.</strong>&nbsp;<strong>Salbutamol</strong>: Also known as albuterol, this is a bronchodilator used to relieve bronchospasm in conditions like asthma. Salbutamol is not commonly associated with skin rashes like a maculopapular rash.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options C.</strong>&nbsp;<strong>Fexofenadine</strong>: This is an antihistamine used for allergic reactions. It is unlikely to cause a maculopapular rash and is more commonly used to treat such rashes when they are due to allergic reactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Amoxicillin, an aminopenicillin antibiotic, is commonly associated with allergic reactions, including maculopapular rashes. This is a well-known side effect of penicillin antibiotics. Prednisolone, salbutamol, and fexofenadine are less likely to cause such reactions, and in the case of prednisolone and fexofenadine, they are actually used to treat allergic reactions and rashes.</span></p>",
      "correct_choice_id": 27839,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7035,
      "choices": [
        {
          "id": 28108,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenobarbitone</span></span></span></p>"
        },
        {
          "id": 28109,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vigabatrin</span></span></span></p>"
        },
        {
          "id": 28110,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethosuximide</span></span></span></p>"
        },
        {
          "id": 28111,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Levetiracetam</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient who was on antiepileptics for the management of seizure disorder started&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">having visual disturbance. Evaluation reveals the contraction of the visual field. The drug&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">responsible is likely to be? (AIIMS NOV 2022)</span></span></span></p>",
      "unique_key": "Q4203688",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993499,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Vigabatrin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vigabatrin is an antiepileptic that works by inhibiting GABA Transaminase. It is used for the treatment of infantile spasms. It is known to cause visual field constriction in some patients. This adverse effect is thought to be due to the drug&#39;s influence on the retina and the central nervous system. Vigabatrin is particularly associated with bilateral concentric visual field constriction, and patients on this medication are often monitored with regular visual field testing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mnemonic</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/18/screenshot-2024-07-18-100536.png\" style=\"height:254px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Phenobarbitone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a barbiturate used to treat epilepsy, but it is not commonly associated with visual field defects. Its side effects may include sedation, dizziness, and cognitive changes, but not specifically visual disturbances like those described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Ethosuximide:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Primarily used for absence seizures, ethosuximide is not typically associated with visual field contractions. Its side effects can include gastrointestinal disturbances, drowsiness, and headaches.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Levetiracetam:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Commonly used in various forms of epilepsy, levetiracetam&#39;s side effects can include drowsiness, weakness, and behavioral changes, but it is not commonly associated with significant visual field disturbances.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vigabatrin is an antiepileptic drug associated with visual field contraction, requiring regular monitoring of visual fields in patients receiving this medication.</span></span></span></p>",
      "correct_choice_id": 28109,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6466,
      "choices": [
        {
          "id": 25833,
          "text": "<p><span style=\"font-size:12.0pt;\">Amoxicillin</span></p>"
        },
        {
          "id": 25834,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythromycin</span></p>"
        },
        {
          "id": 25835,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampicin</span></p>"
        },
        {
          "id": 25836,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetracycline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the drug of choice for diphtheria carrier state? (NEET PG 2019)</span></p>",
      "unique_key": "Q7432347",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993502,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Erythromycin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The drug of choice for the carrier state of diphtheria is erythromycin.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Erythromycin is a macrolide antibiotic that is effective against the bacteria that cause diphtheria. It is used to eradicate the bacteria from carriers and prevent the spread of the disease.</span></li><li><span style=\"font-size:12.0pt;\">Other antibiotics like amoxicillin, rifampicin, and tetracycline are not the first-line treatment for diphtheria carrier state.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Erythromycin is the drug of choice for the carrier state of diphtheria due to its effectiveness in eradicating Corynebacterium diphtheriae from carriers and preventing the spread of the disease. Other antibiotics like amoxicillin, rifampicin, and tetracycline are not considered first-line treatments for this condition.</span></p>",
      "correct_choice_id": 25834,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5484,
      "choices": [
        {
          "id": 21908,
          "text": "<p><span style=\"font-size:12.0pt;\">Aliskiren</span></p>"
        },
        {
          "id": 21909,
          "text": "<p><span style=\"font-size:12.0pt;\">Ramipril</span></p>"
        },
        {
          "id": 21910,
          "text": "<p><span style=\"font-size:12.0pt;\">Losartan</span></p>"
        },
        {
          "id": 21911,
          "text": "<p><span style=\"font-size:12.0pt;\">Spironolactone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drug acts at the site marked by arrow as shown in the diagram? (Fmge Jan 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/4_31lX0YU.jpg\" alt=\"\" width=\"200\" height=\"461\"></span></p>",
      "unique_key": "Q1548306",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055165,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A. Aliskiren</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The arrow is marked at the step where Renin acts and helps in converting Angiotensinogen to Angiotensin I. Angiotensin-I is converted to Angiotensin II with the help of Angiotensin Converting Enzyme (ACE).</span><br>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The drug Aliskiren is a direct competitive renin enzyme inhibitor. Other examples of Renin inhibitors include Remikiren, Enalkiren.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\"><br><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Ramipril</strong>: Is an ACE-Inhibitor. It inhibits the ACE enzyme which catalyze the conversion of Angiotensin I to Angiotensin II.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Losartan</strong>: Is an ARB (Angiotensin Receptor Blocker). It blocks the angiotensin receptor and inhibits its action of vasoconstriction and aldosterone release.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Spironolactone</strong>: Is an Aldosterone blocker. It inhibits the action of Aldosterone of salt and water retention.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Aliskiren acts at the step where renin converts angiotensinogen to angiotensin I, effectively inhibiting the renin enzyme and reducing the downstream effects of the renin-angiotensin-aldosterone system (RAAS). This helps in managing hypertension by reducing vasoconstriction and aldosterone-mediated sodium retention.</span></p>",
      "correct_choice_id": 21908,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7081,
      "choices": [
        {
          "id": 28292,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tmax</span></span></span></p>"
        },
        {
          "id": 28293,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Area under the curve</span></span></span></p>"
        },
        {
          "id": 28294,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cmax</span></span></span></p>"
        },
        {
          "id": 28295,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">t1/2</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The extent of drug absorption in plasma concentration vs time graph is represented by:</span></span>(INICET MAY 2022)</p>",
      "unique_key": "Q4893792",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993323,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Area under the curve</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Area under the curve (AUC) is a measure of the total drug exposure in the bloodstream over time. It reflects the total amount of drug absorbed and is often used to assess the overall bioavailability of a drug. AUC is crucial for determining the efficacy and safety of a medication.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Tmax (Time to Maximum Concentration):</span></strong><span style=\"font-size:12.0pt\"> Tmax represents the time it takes for a drug to reach its maximum concentration (Cmax) in the bloodstream. It tells about rate of drug absorption. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Cmax (Maximum Concentration):</span></strong><span style=\"font-size:12.0pt\"> Cmax represents the highest concentration of a drug in the bloodstream after administration. This parameter is important because it indicates the peak therapeutic effect and helps assess the risk of side effects associated with high drug concentrations.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. t1/2 (Half-Life):</span></strong><span style=\"font-size:12.0pt\"> t1/2 is the time it takes for half of the drug to be eliminated from the bloodstream. It is not directly related to drug absorption but is essential in understanding how long a drug remains in the body and how often it needs to be administered.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Area Under the Curve (AUC) in a plasma concentration vs. time graph represents the extent of drug absorption, reflecting the total drug exposure over time and the overall bioavailability of the drug.</span></span></span></p>",
      "correct_choice_id": 28293,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6460,
      "choices": [
        {
          "id": 25809,
          "text": "<p><span style=\"font-size:12.0pt;\">C is competitive antagonist</span></p>"
        },
        {
          "id": 25810,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿C is more potent than A</span></p>"
        },
        {
          "id": 25811,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿B is more potent than A</span></p>"
        },
        {
          "id": 25812,
          "text": "<p><span style=\"font-size:12.0pt;\">B is competitive antagonist</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true regarding the dose-response curve shown in the image below?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2019)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/204.jpg\" alt=\"\" width=\"400\" height=\"267\"></span></p>",
      "unique_key": "Q2956008",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993322,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) B is competitive antagonist</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This questions tests the knowledge regarding two different things about dose response curve:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">a. Potency and Efficacy: Remember, to take HELP whenever in doubt. It means Height of the curve tells about Efficacy (higher the curve, the more efficacious the drug is) and Left sidedness of the curve tells about Potency (Drugs with curves on left side are more potent than drugs with curve on right side)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">b. Type of Inhibition: If the curve shifts parallelly to right, the drug is a competitive inhibitor, if it shifts down, the drug is a non-competitive inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>What is given in graph:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The DRC of drug B has shifted to the right of the DRC of drug A , although the height of the two curves is the same. On the other hand, Drug C has shifted the curve down.</span></li><li><span style=\"font-size:12.0pt;\">Further height of curve in Drug A and B is same but more than Drug C.</span></li><li><span style=\"font-size:12.0pt;\">Curve of Drug A is on most left followed by Drug C and then Drug B.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Inferences:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, the following inferences can be drawn from the given image:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The efficacy of Drug A = Drug B &gt; Drug C</span></li><li><span style=\"font-size:12.0pt;\">The Potency of Drug A &gt; Drug C &gt; Drug B</span></li><li><span style=\"font-size:12.0pt;\">Drug B is a competitive inhibitor of Drug A</span></li><li><span style=\"font-size:12.0pt;\">Drug C is a non-competitive inhibitor of Drug A</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Efficacy</strong>: The height of the curve represents the efficacy of the drug. The higher the curve, the more efficacious the drug.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Potency</strong>: The position of the curve along the x-axis (left or right) indicates the potency. Drugs with curves on the left side are more potent than those on the right side.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Type of Inhibition</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Competitive Inhibition</strong>: A competitive inhibitor will shift the dose-response curve to the right without changing the maximum effect (efficacy). This indicates that higher concentrations of the agonist can overcome the inhibition.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Non-Competitive Inhibition</strong>: A non-competitive inhibitor will reduce the maximum effect (efficacy) of the agonist, causing a downward shift in the dose-response curve.</span></li></ul>",
      "correct_choice_id": 25812,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6903,
      "choices": [
        {
          "id": 27580,
          "text": "<p><span style=\"font-size:12.0pt;\">1:10000 I.V. - 10 ml</span></p>"
        },
        {
          "id": 27581,
          "text": "<p><span style=\"font-size:12.0pt;\">1:1000 I.M. - 0.5 ml</span></p>"
        },
        {
          "id": 27582,
          "text": "<p><span style=\"font-size:12.0pt;\">1:1000 I.M. - 1 ml</span></p>"
        },
        {
          "id": 27583,
          "text": "<p><span style=\"font-size:12.0pt;\">1:1000 I.V. - 0.5 ml</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What dose of epinephrine is used in anaphylactic shock? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q5093771",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993451,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. 1:1000 I.M. - 0.5 ml</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Epinephrine (1:1000 solution) 0.5 ml via intramuscular route is preferred in the treatment of anaphylactic shock.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/20/screenshot-2023-12-20-103204.jpg\" alt=\"\" width=\"1000\" height=\"398\"></span></p>",
      "correct_choice_id": 27581,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33871,
      "choices": [
        {
          "id": 135322,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">QT prolongation</span></span></p>"
        },
        {
          "id": 135323,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in PR interval</span></span></p>"
        },
        {
          "id": 135324,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ST segment elevation</span></span></p>"
        },
        {
          "id": 135325,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">QRS widening</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the likely ECG changes noted with the use of new anti-tubercular drug bedaquiline:</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Fmge Jan 2024)</span></span></p>",
      "unique_key": "Q8979298",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993447,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) QT prolongation</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The likely ECG change noted with the use of bedaquiline is QT prolongation. This prolongation of the QT interval can increase the risk of cardiac arrhythmias, including a specific type known as Torsades de Pointes. Monitoring of the QT interval is important during bedaquiline therapy, and caution is advised, especially in patients with pre-existing cardiac conditions or those taking other medications that can also prolong the QT interval.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> <strong>Increase in PR interval:</strong> An increase in the PR interval is not a common ECG change associated with bedaquiline use.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong> <strong>ST segment elevation:</strong> ST segment elevation is not a typical ECG change associated with bedaquiline use.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong> <strong>QRS widening:</strong> QRS widening is not a common ECG change associated with bedaquiline use.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective: </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">QT prolongation is a well-documented ECG change associated with the use of bedaquiline. It is one of the notable side effects of this drug.</span></span></p>",
      "correct_choice_id": 135322,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6482,
      "choices": [
        {
          "id": 25897,
          "text": "<p><span style=\"font-size:12.0pt;\">6-Mercaptopurine</span></p>"
        },
        {
          "id": 25898,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitomycin</span></p>"
        },
        {
          "id": 25899,
          "text": "<p><span style=\"font-size:12.0pt;\">Actinomycin</span></p>"
        },
        {
          "id": 25900,
          "text": "<p><span style=\"font-size:12.0pt;\">Asparaginase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old female patient with a history of advanced-stage colorectal cancer is being evaluated for a new chemotherapy regimen. The oncologist is considering drugs that would inhibit DNA synthesis as a part of her treatment. Which of the following drugs is a known inhibitor of DNA synthesis?</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2020)</span></p>",
      "unique_key": "Q8346258",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993446,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 6-Mercaptopurine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">6-Mercaptopurine is a purine analog that acts by inhibiting the purine synthesis, required for the synthesis of DNA, in the S phase of the cell cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Mitomycin</strong> acts as an alkylating agent which leads to DNA damage by creating cross links.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Actinomycin</strong> acts by creating single-strand breaks in DNA. It blocks RNA transcription as well.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>L-Asparaginase </strong>causes the breakdown of asparagine and thus interferes with protein synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">6-Mercaptopurine is a purine analog that inhibits DNA synthesis by interfering with purine synthesis, making it a critical component in chemotherapy regimens that aim to inhibit cell proliferation.</span></p>",
      "correct_choice_id": 25897,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44847,
      "choices": [
        {
          "id": 179035,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone 12 mg 24 hourly 2 doses</span></span></span></p>"
        },
        {
          "id": 179036,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone 6 mg 12 hourly 4 doses</span></span></span></p>"
        },
        {
          "id": 179037,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betamethasone 12 mg 12 hourly 2 doses</span></span></span></p>"
        },
        {
          "id": 179038,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betamethasone 12 mg 24 hourly 4 doses</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old pregnant woman at 32 weeks of gestation presents to the obstetric clinic with signs of preterm labor. The medical team decides to administer corticosteroids to promote fetal lung maturation and reduce the risk of neonatal respiratory distress syndrome. Choose the correct option that should be used for fetal lung maturation: (</span></span></span>INICET May 2024)</p>",
      "unique_key": "Q4116255",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055157,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone 6 mg 12 hourly 4 doses</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For promoting fetal lung maturation in cases of threatened preterm labor, corticosteroids are administered to enhance the production of surfactant, which helps in reducing the risk of neonatal respiratory distress syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The commonly recommended regimens are:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betamethasone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: 12 mg intramuscularly every 24 hours for 2 doses.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: 6 mg intramuscularly every 12 hours for 4 doses.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given these recommendations, the correct options is:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Dexamethasone 6 mg 12 hourly 4 doses</span></span></strong></p>",
      "correct_choice_id": 179036,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6520,
      "choices": [
        {
          "id": 26049,
          "text": "<p><span style=\"font-size:12.0pt;\">Interleukin-10</span></p>"
        },
        {
          "id": 26050,
          "text": "<p><span style=\"font-size:12.0pt;\">Histone deacetylase</span></p>"
        },
        {
          "id": 26051,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine A1</span></p>"
        },
        {
          "id": 26052,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta 2 adrenergic receptors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Theophylline was prescribed to a male patient with chronic obstructive pulmonary disease (COPD). The next day, he noticed that his urine output had increased. Which of the following receptors is responsible for the drug's action?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2022)</span></p>",
      "unique_key": "Q5381441",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055160,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Adenosine A1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Theophylline is a methylxanthine drug that primarily acts as a nonselective adenosine receptor antagonist. By antagonizing adenosine A1 receptors, theophylline can lead to diuresis or increased urine output. Adenosine normally promotes water reabsorption in the renal tubules, and its blockade by theophylline results in increased urine production. This mechanism is separate from its therapeutic action in COPD, which involves bronchodilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Interleukin-10</strong>: Interleukin-10 (IL-10) is an anti-inflammatory cytokine. It is not a direct target of theophylline. IL-10 plays a role in regulating immune responses, but it is not involved in the diuretic effect or the primary action of theophylline in COPD treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Histone Deacetylase</strong>: Histone deacetylase (HDAC) is an enzyme involved in chromatin remodelling and gene expression regulation. While theophylline has been suggested to have some modulatory effects on HDAC, especially in the context of COPD and asthma, it is not the mechanism responsible for the increased urine output observed in the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Beta 2 Adrenergic Receptors</strong>: While theophylline has mild bronchodilatory effects thought to be mediated through inhibition of phosphodiesterase (increasing cAMP levels in smooth muscle), leading to relaxation of bronchial smooth muscles, beta 2 adrenergic receptors are more specifically targeted by drugs like salbutamol. Theophylline's diuretic effect is not mediated through beta 2 adrenergic receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Theophylline increases urine output by antagonizing adenosine A1 receptors, leading to decreased water reabsorption in the renal tubules and resulting in diuresis.</span></p>",
      "correct_choice_id": 26051,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6439,
      "choices": [
        {
          "id": 25725,
          "text": "<p><span style=\"font-size:12.0pt;\">IL-1 receptor antagonist</span></p>"
        },
        {
          "id": 25726,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-CD3 antibody</span></p>"
        },
        {
          "id": 25727,
          "text": "<p><span style=\"font-size:12.0pt;\">IL-2 receptor antagonist</span></p>"
        },
        {
          "id": 25728,
          "text": "<p><span style=\"font-size:12.0pt;\">TNF inhibitor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is basiliximab?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q6808980",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993318,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) IL-2 receptor antagonist</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Basiliximab is a monoclonal antibody that specifically targets and binds with high affinity to the IL-2 receptor, also known as CD25, on the surface of activated T-cells. By antagonizing this receptor, basiliximab inhibits the proliferation of T-cells that are critical for the immune response, thereby helping to prevent transplant rejection. It is commonly used in combination with other immunosuppressive agents to prevent acute rejection in organ transplantation, particularly kidney transplants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. IL-1 receptor antagonist: </strong>IL-1 receptor antagonists, such as anakinra, target the IL-1 receptor and are used in conditions like rheumatoid arthritis. Basiliximab does not target the IL-1 receptor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anti-CD3 antibody: </strong>Anti-CD3 antibodies, such as muromonab-CD3, target the CD3 receptor on T-cells and are used for acute transplant rejection. Basiliximab, however, is not an anti-CD3 antibody.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. TNF inhibitor: </strong>TNF inhibitors, such as infliximab and adalimumab, target tumor necrosis factor (TNF) and are used in autoimmune conditions like rheumatoid arthritis and Crohn's disease. Basiliximab does not inhibit TNF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Basiliximab is an IL-2 receptor antagonist that binds to the CD25 receptor on activated T-cells, thereby preventing T-cell proliferation and helping to prevent transplant rejection reactions. It is specifically used in the context of organ transplantation to reduce the risk of acute rejection.</span></p>",
      "correct_choice_id": 25727,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 64644,
      "choices": [
        {
          "id": 257773,
          "text": "<p><span style=\"font-size:12.0pt;\">Botulinum</span></p>"
        },
        {
          "id": 257774,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetanus</span></p>"
        },
        {
          "id": 257775,
          "text": "<p><span style=\"font-size:12.0pt;\">Diphtheria</span></p>"
        },
        {
          "id": 257776,
          "text": "<p><span style=\"font-size:12.0pt;\">Pertussis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which toxin acts via a mechanism that involves inhibition of neurotransmitter release in the central nervous system by targeting synaptobrevin? (Twisted PYQ)</span></p>",
      "unique_key": "Q6269242",
      "question_audio": null,
      "question_video": null,
      "map_id": 15173102,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Tetanus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Tetanus toxin (produced by Clostridium tetani) acts by cleaving synaptobrevin, a SNARE protein required for the release of inhibitory neurotransmitters like gamma-aminobutyric acid (GABA) and glycine in the central nervous system. This inhibition leads to unchecked excitatory signals, resulting in spastic paralysis, characterized by rigidity and muscle spasms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Botulinum:</strong> Botulinum toxin targets peripheral cholinergic nerve terminals, inhibiting the release of acetylcholine at the neuromuscular junction. This causes flaccid paralysis, not spastic paralysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Diphtheria:</strong> Diphtheria toxin inhibits protein synthesis in host cells by ADP-ribosylation of elongation factor-2 (EF-2), leading to cell death, but does not affect neurotransmitter release.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pertussis:</strong> Pertussis toxin alters G-protein signaling by ADP-ribosylating the Gi protein, impacting cellular communication but not directly inhibiting neurotransmitter release.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Tetanus toxin causes spastic paralysis by cleaving synaptobrevin, disrupting the release of inhibitory neurotransmitters in the CNS. This mechanism contrasts with botulinum toxin, which induces flaccid paralysis by targeting acetylcholine release in peripheral nerve endings.</span></p>",
      "correct_choice_id": 257774,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2019,
      "choices": [
        {
          "id": 8069,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose</span></p>"
        },
        {
          "id": 8070,
          "text": "<p><span style=\"font-size:12.0pt;\">Ketones</span></p>"
        },
        {
          "id": 8071,
          "text": "<p><span style=\"font-size:12.0pt;\">Amino acids</span></p>"
        },
        {
          "id": 8072,
          "text": "<p><span style=\"font-size:12.0pt;\">Fatty Acid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">RBC uses which of the following substances during fasting/starvation? (INICET MAY 2021)</span></p>",
      "unique_key": "Q7356838",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993509,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Glucose</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Under normal physiological conditions, RBCs rely on glucose as their main energy source. Glucose is metabolized through the glycolytic pathway within RBCs to produce ATP, which is essential for maintaining the structural and functional integrity of red blood cells. RBCs lack mitochondria, so they exclusively use anaerobic glycolysis to generate energy from glucose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.&nbsp;<strong>Ketones:</strong> RBCs do not utilize ketones as a significant energy source. Ketones are typically used by other tissues like the brain and muscles during prolonged fasting or starvation when glucose levels are low.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Amino acids:</strong> While amino acids can be used as an energy source by some tissues during fasting or starvation, RBCs primarily rely on glucose and do not extensively use amino acids for energy production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Fatty acids:</strong> RBCs do not use fatty acids as their primary energy source during fasting or starvation. Fatty acid metabolism primarily occurs in tissues with mitochondria, and RBCs lack these organelles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">RBCs always uses glucose whether it is fed state or fasting/starvation state because RBCs lack mitochondria. As ketone body utilization and fatty acid oxidation both take place in mitochondria so, RBCs cannot use fatty acids &amp; ketone bodies as energy source.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Table: Substrates utilized for energy production</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-105602_4CNXu8b.jpg\" alt=\"\" width=\"1000\" height=\"446\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Fetal heart and also in case of heart failure, main fuel is Glucose.</span></li><li><span style=\"font-size:12.0pt;\">Brain cannot use FA as FAs cannot cross blood brain barrier.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong>Ref-Harper 31<sup>st</sup> e/p 138-139</strong></i></span></p>",
      "correct_choice_id": 8069,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44861,
      "choices": [
        {
          "id": 179091,
          "text": "<p><span style=\"font-size:16px;\">Class I and Class II</span></p>"
        },
        {
          "id": 179092,
          "text": "<p><span style=\"font-size:16px;\">Class II and Class III</span></p>"
        },
        {
          "id": 179093,
          "text": "<p><span style=\"font-size:16px;\">Class III and Class IV</span></p>"
        },
        {
          "id": 179094,
          "text": "<p><span style=\"font-size:16px;\">Class IV and Class V</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">According to the World Health Organization's classification, which categories of topical corticosteroids are considered \"High Potency\"?</span></p>",
      "unique_key": "Q8527809",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993497,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Class II and Class III</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The World Health Organization (WHO) has a system for classifying topical corticosteroids based on their potency, which ranges from Class I to Class VII. In this system, Class I is the most potent, and Class VII is the least potent. The classes are divided into groups according to their potency levels. The High Potency group specifically includes Class II and Class III corticosteroids. These classes are distinguished by their molecular activity, concentration, and the nature of their formulation vehicle, making them suitable for more severe dermatological conditions requiring stronger steroid action.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/22/screenshot-2024-05-22-163118.png\" alt=\"\" width=\"1000\" height=\"318\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Class I and Class II</strong>: Incorrect because Class I is categorized under the Ultra-high-potency group, not the High-potency group.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Class III and Class IV</strong>: Incorrect as Class IV falls under the Moderate-potency group rather than the High-potency group.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Class IV and Class V</strong>: Incorrect because both these classes are in the Moderate-potency group, which is lower than the High-potency classification.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Class II and Class III topical corticosteroids are classified as \"High Potency\" according to the WHO classification system.</span></p>",
      "correct_choice_id": 179092,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 64643,
      "choices": [
        {
          "id": 257769,
          "text": "<p><span style=\"font-size:12.0pt;\">Ciprofloxacin and ORS</span></p>"
        },
        {
          "id": 257770,
          "text": "<p><span style=\"font-size:12.0pt;\">Only ORS</span></p>"
        },
        {
          "id": 257771,
          "text": "<p><span style=\"font-size:12.0pt;\">Ciprofloxacin and tinidazole</span></p>"
        },
        {
          "id": 257772,
          "text": "<p><span style=\"font-size:12.0pt;\">Ciprofloxacin, tinidazole, and ORS</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young male developed 5 episodes of loose stools 2 hours after eating in a restaurant. He is febrile and has moderate dehydration. What should be the treatment?(Twisted PYQ)</span></p>",
      "unique_key": "Q7243557",
      "question_audio": null,
      "question_video": null,
      "map_id": 15173101,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Ciprofloxacin and ORS</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In febrile patients with diarrhea, the suspicion of a bacterial etiology such as invasive enteric pathogens (e.g., Salmonella, Shigella, or Campylobacter) increases. Empirical antibiotic therapy with ciprofloxacin is indicated in this case to address the bacterial infection. ORS is essential for rehydration to replace fluid and electrolyte losses due to moderate dehydration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Only ORS:</strong> ORS alone is insufficient in this case because the patient has fever and signs suggesting a bacterial cause, necessitating antibiotic treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ciprofloxacin and tinidazole:</strong> While ciprofloxacin is appropriate, tinidazole is unnecessary unless a protozoal infection like amoebiasis or giardiasis is suspected, which is not indicated here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ciprofloxacin, tinidazole, and ORS:</strong> Adding tinidazole without clear evidence of protozoal infection would be inappropriate and could lead to unnecessary side effects or resistance. Ciprofloxacin with ORS is adequate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In patients with acute diarrhea and fever, empirical antibiotic therapy (e.g., ciprofloxacin) is indicated along with ORS for rehydration. Antibiotics should be avoided in afebrile patients with mild dehydration, where ORS alone suffices.</span></p>",
      "correct_choice_id": 257769,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51443,
      "choices": [
        {
          "id": 205293,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Ezetimibe</span></p>"
        },
        {
          "id": 205294,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Niacin</span></p>"
        },
        {
          "id": 205295,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Gemfibrozil</span></p>"
        },
        {
          "id": 205296,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Evolocumab</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 55-year-old male patient with a history of hyperlipidemia was started on statins for elevated triglyceride levels. Despite the statin therapy, his triglyceride levels remain persistently elevated at over 600 mg/dL. Which of the following medications should be administered next to help manage his triglyceride levels? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q5361156",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055162,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C) Gemfibrozil</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Gemfibrozil belongs to the class of drugs known as <strong>fibrates.</strong> Fibrates are particularly effective in lowering triglyceride levels, which is critical in this patient’s case given the significantly elevated triglyceride level over 600 mg/dL. This level puts the patient at increased risk of developing pancreatitis, a serious and potentially life-threatening condition. Fibrates, such as gemfibrozil, work by activating peroxisome proliferator-activated receptor-alpha (PPAR-alpha), which increases the oxidation of fatty acids and decreases triglyceride levels.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. Ezetimibe:</strong> This medication works by inhibiting the absorption of cholesterol in the intestines. It is primarily used to lower LDL cholesterol and has a minimal effect on triglyceride levels. It would not be effective in this scenario where significant triglyceride lowering is needed.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. Niacin:</strong> Niacin, also known as vitamin B3, is effective in increasing HDL cholesterol but is less effective than fibrates in lowering triglycerides. It is not the first choice in managing severe hypertriglyceridemia like in this case.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Evolocumab:</strong> Evolocumab is a PCSK9 inhibitor used primarily to lower LDL cholesterol, especially in patients with homozygous familial hypercholesterolemia. It is not indicated for the treatment of elevated triglycerides and would not be effective in this case.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">For patients with significantly elevated triglyceride levels (over 600 mg/dL) that do not respond adequately to statins, fibrates like gemfibrozil are the next step in management to reduce the risk of pancreatitis.</span></p>",
      "correct_choice_id": 205295,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30720,
      "choices": [
        {
          "id": 122758,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-A, 2-E, 3-B, 4-C</span></span></span></p>"
        },
        {
          "id": 122759,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-F, 2- E, 3-D, 4- B</span></span></span></p>"
        },
        {
          "id": 122760,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">1-F, 2-E, 3-B, 4-A</span></span></span></span></p>"
        },
        {
          "id": 122761,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-B, 2-C, 3-D, 4-E</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Match&nbsp;</span></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">the following drugs poisoning with the antidotes:(AIIMS MAY 2019)&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-163314.png\" style=\"height:498px; width:1000px\" /></p>",
      "unique_key": "Q3684140",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055156,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans.&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">C. 1-F, 2-E, 3-B, 4-A</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">1. HCN (Hydrogen Cyanide):</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antidote: <strong>F. Amyl nitrite</strong><br />\r\n\tHCN poisoning, also known as cyanide poisoning, is treated with amyl nitrite, which induces methemoglobinemia, allowing cyanide to bind to methemoglobin instead of cytochrome oxidase, reducing its toxicity. The DOC for cyanide poisoning is Hydroxocobalamine.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">2. Paracetamol (Acetaminophen):</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antidote: <strong>E. N-acetylcysteine</strong><br />\r\n\tN-acetylcysteine replenishes glutathione stores, helping detoxify the reactive metabolite of paracetamol, thereby preventing liver damage.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">3. Morphine:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antidote: <strong>B. Nalorphine</strong><br />\r\n\tNalorphine is an opioid antagonist used to counteract the effects of opioid overdose, including morphine.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4. Nicotine:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antidote: <strong>A. Trimethadione</strong><br />\r\n\tTrimethadione is used in cases of nicotine poisoning due to its ganglionic blocking properties, similar to the Nn receptor blockers (ganglionic blockers) like Trimethaphan and Hexamethonium.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">HCN poisoning:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">DOC is Hydroxocobalamin. Amyl Nitrite(inhalational) with sodium thiosulphate (iv) can also be used.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Paracetamol poisoning (causes hepatoxicity):&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">N-acetylcysteine is used.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Morphine poisoning:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">DOC is Naloxone. Nalorphine can also be used.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Nicotine poisoning:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Trimethaphan and Hexamethonium &ndash; Nn receptor blockers </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:40px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">(ganglionic blockers) are used.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: - KDT 8<sup>TH</sup>/590, 223, 509, 134</span></span></strong></span></span></p>",
      "correct_choice_id": 122760,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20913,
      "choices": [
        {
          "id": 83616,
          "text": "<p><span style=\"font-size:12.0pt;\">Postural hypotension</span></p>"
        },
        {
          "id": 83617,
          "text": "<p><span style=\"font-size:12.0pt;\">Receptor upregulation</span></p>"
        },
        {
          "id": 83618,
          "text": "<p><span style=\"font-size:12.0pt;\">Rebound hypertension</span></p>"
        },
        {
          "id": 83619,
          "text": "<p><span style=\"font-size:12.0pt;\">Receptor hypersensitivity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A chronic smoker was on nicotine replacement therapy and clonidine tablets for smoking de-addiction. He stopped taking clonidine tablets and now presents with a headache. What is the reason behind this condition? (NEET PG 2023)</span></p>",
      "unique_key": "Q5822746",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993841,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Rebound hypertension</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clonidine is an alpha-2 agonist and a centrally acting antihypertensive agent. Used in HTN. Stimulates presynaptic α-receptor in the vasomotor centre in the brainstem, suppressing the release of norepinephrine and other sympathomimetics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clonidine sudden stoppage causes Rebound HTN and sympathetic overactivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment of clonidine withdrawal is Phentolamine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Postural Hypotension</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Description:</strong> A condition where blood pressure drops significantly upon standing up.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance:</strong> Clonidine can cause postural hypotension, but sudden discontinuation leads to rebound hypertension, not postural hypotension.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Receptor Upregulation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Description:</strong> An increase in the number of receptors on the cell surface.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance:</strong> This concept is more related to long-term exposure to antagonists, not the sudden withdrawal of an agonist like clonidine.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Receptor Hypersensitivity</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Description:</strong> Increased sensitivity of receptors to a stimulus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance:</strong> While receptor hypersensitivity can occur, it is not the primary mechanism behind the headache and rebound hypertension seen with sudden clonidine withdrawal.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Rebound hypertension</strong> is a critical condition that can occur when clonidine, an alpha-2 agonist, is suddenly discontinued. This results in a rapid increase in sympathetic activity, leading to symptoms such as headache due to a sudden spike in blood pressure.</span></p>",
      "correct_choice_id": 83618,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9932,
      "choices": [
        {
          "id": 39694,
          "text": "<p><span style=\"font-size:12pt;\">Psoriasis vulgaris</span></p>"
        },
        {
          "id": 39695,
          "text": "<p><span style=\"font-size:12pt;\">Leishmaniasis</span></p>"
        },
        {
          "id": 39696,
          "text": "<p><span style=\"font-size:12pt;\">Mycosis fungoides</span></p>"
        },
        {
          "id": 39697,
          "text": "<p><span style=\"font-size:12pt;\">Pemphigus vulgaris</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">The histopathology picture below is suggestive of? (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13496.jpg\" alt=\"\" width=\"300\" height=\"217\"></p>",
      "unique_key": "Q8832810",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993321,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Pemphigus vulgaris</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The given slide shows a <strong>row of tombstones' appearance</strong>, which is classically seen in Pemphigus vulgaris.</span></li><li><span style=\"font-size:12pt;\">The production of <strong>antibodies, specifically those against Desmoglein 3</strong>, is seen in Pemphigus vulgaris.</span></li><li><span style=\"font-size:12pt;\"><strong>Desmoglein 1&nbsp;</strong>antibodies are also occasionally associated.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture29.jpg\" alt=\"\" width=\"600\" height=\"559\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Usually, the antibodies are <strong>IgG antibodies</strong>. The skin and mucosa's <strong>basal and suprabasal</strong> layers contain the majority of <strong>Desmoglein 3</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Hemidesmosomes&nbsp;</strong>help in connecting <strong>basal layer </strong>to underlying <strong>dermo-epidermal junction</strong>, in <strong>pemphigus vulgaris</strong> there are <strong>no antibodies</strong> against <strong>Hemidesmosomes</strong>, so the basal layer remains attached to the underlying dermo-epidermal junction giving the classical <strong>Row of tombstones appearance</strong>.</span></li><li><span style=\"font-size:12pt;\">The patients, therefore, present with <strong>flaccid bullae over the skin</strong> and due to Desmoglein 3 involvement, mucosal involvement can also be seen.</span></li><li><span style=\"font-size:12pt;\"><strong>Oral mucosa is commonly affected</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture30.jpg\" alt=\"\" width=\"400\" height=\"266\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Other areas where ulceration can be seen are <strong>conjunctiva</strong>, <strong>nasopharynx, larynx</strong>, etc.</span></li><li><span style=\"font-size:12pt;\">Cutaneous lesions are more common over the <strong>scalp, face, neck, upper chest, and back as seen in the image below.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture31.jpg\" alt=\"\" width=\"400\" height=\"302\"></strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Biopsy:&nbsp;</strong>The basal layer remains adherent to the basement membrane and gives the resemblance to a <strong>row of tombstones.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13497.jpg\" alt=\"\" width=\"600\" height=\"214\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">IMAGE of row of tombstones appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Psoriasis vulgaris:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is an <strong>autoimmune</strong> disease characterized by <strong>hyperproliferation of keratinocytes</strong> leading to thickened, <strong>scaly plaques</strong>.</span></li><li><span style=\"font-size:12pt;\">Histologically, it shows <strong>parakeratosis</strong> (<strong>retention of nuclei </strong>in the stratum c<strong>orneum</strong>), elongation of <strong>rete ridges</strong>, and a <strong>neutrophilic </strong>infiltrate (<strong>Munro's </strong>microabscesses) as shown in the image below.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture32.jpg\" alt=\"\" width=\"400\" height=\"178\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The tombstone appearance is not a feature of psoriasis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Leishmaniasis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It's a <strong>parasitic</strong> infection caused by the <strong>Leishmania</strong> species.</span></li><li><span style=\"font-size:12pt;\">Histologically, it is characterized by <strong>macrophages</strong> containing the <strong>parasite</strong> <strong>(Leishman-Donovan bodies</strong>) in the <strong>dermis </strong>as shown in the image below.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture33.jpg\" alt=\"\" width=\"400\" height=\"398\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The tombstone appearance is not seen in leishmaniasis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Mycosis fungoides:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is a type of <strong>cutaneous T-cell lymphoma</strong>.</span></li><li><span style=\"font-size:12pt;\">Histologically, there is an <strong>atypical lymphocytic </strong>infiltrate in the epidermis <strong>(epidermotropism</strong>), and the formation of <strong>Pautrier's microabscesses </strong>(collections of l<strong>ymphocytes</strong> in the epidermis) as shown in the image below.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture34.jpg\" alt=\"\" width=\"400\" height=\"227\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It does <strong>not</strong> exhibit a <strong>tombstone appearance</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/screenshot-2023-11-27-180630.jpg\" alt=\"\" width=\"1000\" height=\"596\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The histopathology image suggests <strong>Pemphigus vulgaris</strong>, which is characterized by <strong>intraepidermal blistering</strong> due to <strong>acantholysis</strong>, or <strong>separation of keratinocytes</strong>, as a result of <strong>autoantibody</strong> attack on <strong>desmosomal proteins.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rook's Textbook of Dermatology - 9th Edition Chapter 50 Page no 50.1</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Robbins &amp; cotran Pathologic Basis of disease 10e- page no 1160</strong></span></p>",
      "correct_choice_id": 39697,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7150,
      "choices": [
        {
          "id": 28568,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blockers</span></span></span></p>"
        },
        {
          "id": 28569,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium channel blockers</span></span></span></p>"
        },
        {
          "id": 28570,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetaminophen</span></span></span></p>"
        },
        {
          "id": 28571,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspirin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary alkalinization will be most useful in toxicity of which of the following drugs? (INICET NOV 2020)</span></span></p>",
      "unique_key": "Q3639351",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993495,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Aspirin</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary alkalinization is a key treatment in aspirin toxicity. Aspirin (salicylate) is a weak acid, and alkalinizing the urine increases the ionization of salicylates. This ionization traps salicylates in the urine, preventing their reabsorption and enhancing their elimination.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Beta blockers:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Urinary alkalinization is not a standard treatment for beta blocker toxicity. Management of beta blocker overdose typically involves supportive care and, in severe cases, specific antidotes like glucagon or high-dose insulin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Calcium channel blockers:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Similar to beta blockers, urinary alkalinization is not a primary treatment for calcium channel blocker overdose. Treatment often includes calcium infusions, glucagon, and other supportive measures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Acetaminophen:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> For acetaminophen toxicity, the antidote N-acetylcysteine (NAC) is used. Urinary alkalinization is not effective for acetaminophen overdose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary alkalinization is most useful in the treatment of aspirin (salicylate) toxicity because it increases the elimination of salicylates by trapping them in the urine through ionization. This method is not effective for beta blockers, calcium channel blockers, or acetaminophen toxicity.</span></span></span></p>",
      "correct_choice_id": 28571,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6990,
      "choices": [
        {
          "id": 27928,
          "text": "<p><span style=\"font-size:12.0pt;\">Schedule M drugs</span></p>"
        },
        {
          "id": 27929,
          "text": "<p><span style=\"font-size:12.0pt;\">Schedule H drugs</span></p>"
        },
        {
          "id": 27930,
          "text": "<p><span style=\"font-size:12.0pt;\">Schedule J drugs</span></p>"
        },
        {
          "id": 27931,
          "text": "<p><span style=\"font-size:12.0pt;\">Schedule X drugs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs should be sold only on prescription from a registered medical practitioner? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q5233547",
      "question_audio": null,
      "question_video": null,
      "map_id": 14993448,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Schedule H drugs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Under the \"Drugs and Cosmetics Act,\" certain schedules classify drugs based on various criteria, including the need for prescription, potential for abuse, and manufacturing practices.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Schedule H drugs</strong>: These drugs can only be sold with a prescription from a registered medical practitioner. They are labeled with \"Rx\" written in black color to indicate that they should be dispensed only on prescription.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Schedule M drugs</strong>: These pertain to Good Manufacturing Practices (GMP) for pharmaceuticals and do not indicate a requirement for prescription-based sale.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C</strong>. <strong>Schedule J drugs</strong>: This schedule lists diseases and ailments for which a drug may not claim to prevent or cure. It does not pertain to prescription requirements.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D</strong>. <strong>Schedule X drugs</strong>: These are psychotropic substances with a high potential for abuse and must be sold with a valid prescription. While Schedule X drugs also require a prescription, the question specifically asks about drugs that should be sold only on prescription from a registered medical practitioner, making Schedule H drugs the correct answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The important schedules under the “Drugs and Cosmetics Act” are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Schedule H</strong> – The drugs that can be sold only by prescription where Rx is written in black color.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule H1</strong> – for antibiotics where Rx is written in red color.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule G</strong> – Drugs that need labelling as “Dangerous to use except under medical supervision.”</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule X</strong> – Psychotropic drugs that have a high abuse liability and are to be sold with a valid prescription only.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule P drug</strong> – describes the life period of drugs in months (unless otherwise specified) between the date of manufacture and date of expiry.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule M</strong> – GMP or Good Manufacturing Practices.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule J </strong>- List of diseases and ailments which a drug may not claim to prevent or cure</span></li></ul>",
      "correct_choice_id": 27929,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44779,
      "choices": [
        {
          "id": 178763,
          "text": "<p><span style=\"font-size:12pt;\">Acetylcholine</span></p>"
        },
        {
          "id": 178764,
          "text": "<p><span style=\"font-size:12pt;\">Dopamine</span></p>"
        },
        {
          "id": 178765,
          "text": "<p><span style=\"font-size:12pt;\">Epinephrine</span></p>"
        },
        {
          "id": 178766,
          "text": "<p><span style=\"font-size:12pt;\">Nor Epinephrine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following neurotransmitters is released from SA node in response to increase in blood pressure?</span></p>",
      "unique_key": "Q6824575",
      "question_audio": null,
      "question_video": null,
      "map_id": 15055228,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Acetylcholine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Acetylcholine is the primary neurotransmitter released by the parasympathetic nervous system. When blood pressure increases, baroreceptors in the carotid sinus and aortic arch detect this change and stimulate the parasympathetic nervous system. This leads to the release of acetylcholine from the vagus nerve at the SA node, resulting in a decrease in heart rate (bradycardia) and a reduction in cardiac output, which helps to lower blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;B.</strong>&nbsp;<strong>Dopamine</strong>: Dopamine is a neurotransmitter involved in several central nervous system functions, including movement and reward. It is not directly involved in the regulation of heart rate or blood pressure in the context of the SA node.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Epinephrine</strong>: Epinephrine (adrenaline) is released by the adrenal medulla and acts on both alpha and beta adrenergic receptors. It generally increases heart rate and blood pressure. It is not released from the SA node in response to increased blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Norepinephrine</strong>: Norepinephrine is a neurotransmitter released by the sympathetic nervous system. It acts on alpha and beta adrenergic receptors to increase heart rate and blood pressure. However, in response to increased blood pressure, the sympathetic activity is typically reduced, and norepinephrine release is decreased.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, the correct neurotransmitter released from the SA node in response to an increase in blood pressure is acetylcholine, as it is part of the parasympathetic response to decrease heart rate and lower blood pressure.</span></p>",
      "correct_choice_id": 178763,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}